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ABSTRACT

ROLE OF BOVINE ILEAL SUB-EPITHELIAL MYOFIBROBLASTS AND
EPITHELIAL CELLS IN INNATE IMMUNITY
TIRTH UPRETY
2018
Gastro-intestinal (GI) tract harbors largest number of microbiota as well as the
largest number of immune cells for a given tissue. The host needs to mount an effective
immune response against invading pathogens and tolerance against commensals. Thus,
regulatory mechanism and barrier function of the GI tract are of utmost importance for
appropriate host microbe interaction and gut homeostasis. Intestinal epithelial cells
(IECs) act as the first line of defense against invading pathogens. IECs recognize
pathogens and commensals and mount an effective innate immune response. Such
recognition of pathogens is mediated through germ line encoded pattern recognition
receptors (PRRs). Intestinal sub-epithelial myofibroblasts (ISEMFs) reside just beneath
the surface epithelium and are involved in maturation and differentiation of epithelium.
ISEMFs protect from pathogens that breach surface epithelium by expressing PRRs. Lack
of stable intestinal epithelial and sub-epithelial myofibroblast cell lines has slowed down
scientific studies on these cells. In this study, we established and characterized ISEMF
cells from the ileum of a 2-day old calf. We also had generated stable bovine ileal
epithelial cell (BIEC-c4) cultures in our lab. On real time-quantitative polymerase chain
reaction (RT-qPCR) analysis both these cell types expressed Toll-like receptors (TLRs)
1-9. To investigate their responses to various pathogen-associated molecular patterns
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(PAMPs), we stimulated both cell types for 3 hours and 24 hours with various PAMPs.
The RT-qPCR assay was used to investigate changes in TLR gene expression and in
cytokine genes following stimulation. Lipopolysaccharide, peptidoglycan, and flagellin
were used as bacterial ligands of surface PRRs. Similarly, γ-D-Glu-mDAP, muramyl
dipeptide, polyinosonic:polycytidylic acid, poly I:C complexed with lyovec, and
imiquimod were used as ligands of cytosolic and endosomal PRRs. Bovine ileal ISEMFs
responded to bacterial PAMPs and to ligands of cytosolic and endosomal PRRs by
significantly altering TLR gene expression. Unlike bovine ISEMFs, BIEC-c4 cells
responded only to bacterial ligands. Thus, we conclude that bovine ileal ISEMF can be a
good model to study innate immune responses and signaling pathways occurring at subepithelial compartment. However, BIEC-c4 cells may serve as a good in-vitro model to
study enteric infectious disease pathogenesis and innate immune responses associated
with them.
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Chapter 1. Introduction and Objectives
1.1 Introduction
Humans and animals being constantly exposed to myriad pathogens, within and
outside of the body, need a robust system that can rapidly respond to invading pathogens.
The immune system has evolved with evolving pathogens into an intricate system where
it is difficult to compartmentalize it into sub-systems. In general, the immune system can
be broadly classified into innate immunity and adaptive immunity.
Innate immunity comprises of anatomical barriers and germ line encoded
receptors that recognize molecular patterns conserved across microorganisms and
pathogens whereas adaptive or acquired immunity relies mainly on T-cell and B-cell
responses against pathogens. Traditionally, innate immunity was characterized as nonspecific immunity, but a recent understanding of innate immune system has shown the
specificity in recognizing a virus or bacteria or intracellular and extracellular pathogens.
Innate immunity’s ability to recognize danger associated molecular patterns (DAMPs)
that arise after necrotic cell death restricts the extensive cellular damage. Moreover, to
mount a strong adaptive immune response requires stimulatory signaling from the innate
immune system. Innate immunity’s rapid response to invading pathogens precedes that of
adaptive immunity and thus is important in limiting initial invasion by pathogens. Recent
understanding of the significance of innate immunity has led to a renaissance of
researches aimed at the better understanding the molecular mechanism of innate immune
responses.
One of the various methods of pathogen recognition by the innate immune system
is through recognition of pathogen associated molecular pattern (PAMPs) and the
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recognizing receptors are pattern recognition receptors (PRRs). Toll-like receptors
(TLRs) are transmembrane proteins that are part of PRR family and recognize conserved
regions in bacteria, viruses, fungi or protozoa through leucine-rich repeat in their
extracellular domain. Researchers are aiming at harnessing the potential therapeutic
application of TLR signaling, especially in vaccine synthesis where TLR agonist are used
as adjuvants for eliciting a strong immune response. Such a novel approach includes
vaccination strategies for influenza vaccine (1), Mycobacterium tuberculosis vaccine (2),
cancer vaccine like human papilloma virus (HPV) (3). A better understanding of cellular
responses to various TLR agonists will help in designing approaches to manipulate
immune response for therapeutic purposes. These PRRs constantly interact with
microorganisms and mount a pro-inflammatory or anti-inflammatory response,
whichever deemed essential.
Of various sites of host-microbe interaction, the gut epithelium is of utmost
importance as it harbors trillions of commensals and pathobionts forming an ecological
community called as gut microbiota. Intestinal epithelial cells have two major functions,
segregation of gut microbiota and host intestine and mediate signals between microbiota
and immune cells. Intestinal epithelial cells are constantly producing antimicrobial
peptides, mucins, cytokines like IL-12, IL-27, IL-17 and chemokines to ward off
pathobionts and pathogens (4). Constant production of pro-inflammatory cytokines by
intestinal epithelial cells can lead to disease like Inflammatory Bowel Disease (IBD).
Thus, intestinal epithelial cells need to balance the pro- and anti- inflammatory immune
response. Just beneath the intestinal mucosa lies mesenchymal cells notably fibroblasts
and myofibroblasts. These cells provide structural support as well as play vital role in
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maturation and differentiation of epithelial cells (5) and in immune regulation at mucosal
and sub mucosal levels (6). Many studies have focused to understand their role in innate
immunity when the first line of defense is compromised.
In vivo efforts to better understand the mechanisms by which intestinal epithelial
cells maintain the harmony between pro and anti-inflammatory responses in response to
constant interaction with gut microbiota is challenging. In vitro studies on intestinal
epithelial cells enable to investigate mechanisms at cellular and molecular level.
Researchers routinely use cell lines to study biological processes, however, unavailability
of genotypically and phenotypically characterized bovine intestinal epithelial cell lines
and intestinal sub-epithelial myofibroblast cell lines has made it difficult to study innate
immune responses at intestinal mucosal and sub-mucosal level in bovine species. The
development and characterization of a stable bovine intestinal sub-epithelial
myofibroblast cell line will help us to investigate immune responses occurring beneath
the mucosal level. The study proposed here will serve to understand the responses of
intestinal epithelial cells and intestinal sub-epithelial myofibroblasts to various bacterial
and viral ligands in terms of expression of TLRs,cytokines and chemokines. The research
findings will help researchers in designing approaches to use TLR agonists for further
immune system modulation and therapeutic strategies.
1.2 Objectives
The objectives of the study:
1. To establish and characterize a stable bovine intestinal sub-epithelial
myofibroblast (ISEMF) cell line from the ileum of the 2-day old calf.
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2. To analyze and study the expression of Toll like receptors (TLRs) by ISEMFs and
investigate their responses to pathogen associated molecular patterns (PAMPs).
3. To analyze and study the expression of Toll like receptors (TLRs) by bovine
intestinal epithelial cells line (BIEC-c4) and investigate its responses to pathogen
associated molecular patterns (PAMPs).
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Chapter 2. Review of literature
2.1 An overview of the immune system
Edward Jenner by vaccinating against small pox laid the foundation for research
into the field of Immunology. Shibasaburo Kitasato and Emil von Behring led the
foundation for passive immunization by using antitoxins against tetanus. This led Paul
Ehrlich to propose side chain theory which later was considered as a mechanism of
antibody production from B-cell. Elie Metchnikoff observed cells that could engulf
bacteria and coined them as phagocytes. In doing so, he laid the foundation for studies on
innate immunity (7). During the early phase, scientists debated on what protected the
body from pathogens. Some argued for cells like phagocytes while other supported
humoral components like the then antitoxins (antibodies). Early research in immunology
was dominated by humoral immunology as it could explain many immunopathologies.
Later dichotomies like delayed type hypersensitivity and allograft rejection led to an
appreciation of cell-mediated immunity.
The immune system has evolved considerably over the course of evolution. From
toxic peptides and gene inactivating process to forestall pathogens employed by simplest
eukaryotes to development of an arsenal of cells capable of detecting pathogens and
mounting a specific response in higher vertebrates, it has developed into a complex
system with no single definition to address this complexity (8).
The immune system is an intricate network of immune and non-immune cells,
tissues, and organs that protect the body from pathogens and harmful substances. Broadly
the immune system can be classified into innate immunity and adaptive immunity and the
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four major components of the immune system are barrier functions, immune tissues,
immune cells, and protein/peptide defense (9).
2.2 Components of innate immunity
Innate immunity relies on germ line encoded receptors to mount an immune
response against invading pathogens. Initially, it was considered as non-specific
immunity. Research in the field of innate immunity has led to discoveries that show
innate immunity to be specific. More than 90% of animal species rely solely on innate
immunity for protection against pathogens (8).
Anatomical and physiological barriers provide initial defense against pathogens.
These barriers include skin, cilia, low pH of the intestine, and antimicrobial peptides.
Innate immunity along with the barriers serves as the first line of defense. Traditionally
innate immunity was described only as host component. Efflux of information from
microbiome studies has shown that innate immunity is a result of complex interplay
between host and microbes.
Innate immunity relies on physical barriers, germ line encoded receptors,
complement proteins, phagocytic cells, innate effector cells, and regulatory molecules
like chemokines and cytokines (10). The absence of immunological memory separates
innate immunity from adaptive immunity. Recent studies have shown a paradigm shift as
innate immunity is shown to have some degree of immunological memory (11, 12).
Innate immune cells like macrophages and natural killer cells (NK cells) upon
reintroduction of similar infection show enhanced immunity. This enhanced immunity is
independent of either B-cell or T-cell and is termed as ‘trained immunity’. This trained
immunity could result from metabolic reprogramming of innate immune cells (13, 14).
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Such immunological memory is also observed in copepods that lack an adaptive immune
system and could possibly be a function of innate lectins (11). Trained immunity is also
shown to exist in disease models of human neonates (15).
2.2.1 Pattern Recognition Receptors (PRRs)
In 1989 Charles Janeway Jr proposed the Pattern Recognition Receptor (PRR)
theory. The central theme of this theory was that immune cells have receptors that
recognize the microbial pattern and mount an effective immune response and provide
necessary co-stimulation to an adaptive immune system for the further response (16).
Such microbial patterns are conserved across the microbial groups and called as pathogen
associated molecular patterns (PAMPs) or microbe associated molecular patterns
(MAMPs). There are 6 families of these PRRs (17):
i.

Toll-like receptors (TLRs)

ii.

C-type Lectins

iii.

Nod-like receptors (NLRs)

iv.

RIG-I like receptors (RLRs)

v.

AIM-2 like receptors (ALRs)

vi.

OAS-like receptors (OLRs)

2.2.1.1 Toll like receptors (TLRs)
Toll-proteins were initially identified in Drosophila as a transmembrane protein
involved in the organization of dorso-ventral polarity of embryos (18). Later in 1996,
researchers identified that Toll protein was involved in protection against fungal infection
(19). A detailed history of discoveries in TLR study is enlisted in Fig 1 which is adapted
from (20).
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Fig 1: The history of Toll like receptors. Figure adapted from (20)
TLRs are a type-I transmembrane glycoproteins with N-terminal ligand
recognition domain, single transmembrane helix, and C-terminal cytoplasmic signaling
domain. The cytoplasmic region has considerable homology to other receptors of
Interleukin-1 receptors family (IL-1R) and thus signaling domains of TLR is called as
Toll/Interleukin-1 receptor (TIR) domain. The transmembrane domain contains a stretch
of nearly 20 hydrophobic residues. TLRs that sense nucleic acid PAMPs use the
transmembrane domain to interact with nucleic acid PAMPs and directs these TLRs to
endocytic compartments (21, 22). The ectodomain region of TLR is different from that of
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IL-1R. TLR ectodomain contains leucine rich repeats which are stretch of 22-29
hydrophobic residues in distinct interval involved in sensing of pathogens and the
cytoplasmic region is involved in signal transduction (23, 24). Synthesis of TLR occurs
in Endoplasmic Reticulum which is then trafficked to Golgi and ultimately recruited to
the cell surface or to endosomes (25). Most mammals have ten TLRs (TLR 1-10) while a
mouse has 13 TLRs (TLR 10 being a pseudogene) (26, 27). Sensing of PAMPs occurs
through TLR ectodomain. PAMPs associated with various PRRs are listed in Table 1.
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Table 1: TLR specific ligands. Adapted from (23).

2.2.1.1.1 TLR signaling
Sensing of PAMPs by TLRs leads to homo-dimerization or hetero-dimerization of
TLR ectodomain. Dimerization of TLR ectodomains brings cytoplasmic domains near for
dimerization and initiate downstream signaling (28-31). Dimerization of the cytoplasmic
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domain is essential for the recruitment of signaling molecules. Downstream signaling
molecules include adaptor protein called myeloid differentiation primary-response
protein 88 (MyD88), IL-1R associated Kinases (IRAKs), transforming growth factor -β
(TGF-β)-activated kinase (TAK1), TAB2, and tumor necrosis factor (TNF)-receptor
associated factor 6 (TRAF6) (32, 33).
2.2.1.1.1.1 MyD88 dependent signaling
The MyD88 protein has a death domain (DD) at N-terminal and a cytoplasmic
TIR domain. MyD-88 recruits IRAK to IL-1R complex by the interaction of DDs. It
forms a homodimer of DD-DD and TIR domain-TIR domain when recruited to the
receptor complex. It acts as an adaptor to recruit downstream signaling molecules that
have DDs. MyD88 recruits IRAKs to form a complex called myddosome. Four different
IRAK -like kinases have been identified (IRAK-1, IRAK-2, IRAK-4, IRAK-M). MyD88
interacts with IRAK 4, IRAK 4 phosphorylates IRAK 1. Auto phosphorylated IRAK 1
becomes fully functional. It then dissociates from the receptor complex. Fully functional
IRAK 1 after dissociating from receptor complex activates ubiquitin E3 ligase TRAF 6
which is an ubiquitin protein ligase. Ubiquitination of TRAF 6 recruits TAK/TAB and
IKK complexes. TAK is major complex that activates mitogen activated protein kinases
(MAPK) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB)
along with Janus kinase (JNK), extracellular signal regulated kinases (ERK), and p38
pathway. TLR signaling mainly activates p65/p50 heterodimer of NF-κB family which
leads to the production of pro-inflammatory cytokines, chemokines and co-stimulatory
molecules (7, 23, 34-37).
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2.2.1.1.1.2 MyD88 independent pathway/TRIF-dependent signaling pathway
TRIF (TIR-domain-containing adapter-inducing interferon-β ) consists of N
terminal domain, TRAF 6 binding motif, a TIR domain and RHIM domain (Receptor
interacting protein (RIP) homotyping interaction motif). RIP homotypic motif is essential
for association with RIP 1. RIP 1mediates NF-κB activation. Signaling through TRIF
leads to activation of transcription factors like NF-κB, IRF3 (Interferon regulatory factor
3), and activator protein 1 (AP 1). Phosphorylation activates C terminal regulatory
domain of IRF3 which forms a dimer. After dimerization IRF3 is translocated to the
nucleus. IRF 3 in nucleus recruits co-activators like p300 and CBP (cAMP-responsiveelement-binding protein (CREB)-binding protein. These co-activators activate
transcription of type-I IFN. Type I IFN activates IFN inducible genes (7, 23, 37-42).
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Fig 2: PRR signaling pathway along with regulator of signaling. Adapted from (43)
2.2.1.1.2 Negative regulation of TLR signaling
An excessive inflammatory cytokine produced during consistent TLR signaling
may lead to endotoxic shock and systemic disorder. A negative regulation of TLR
signaling occurs primarily through 3 major mechanisms. Dissociation of adaptor
complexes, degradation of signal proteins, and transcriptional regulation all lead to
negative regulation of TLR signaling. Molecules like suppressor of cytokine signaling 1
(SOCS1), IRAK M, MyD88 short (MyD88s), single immunoglobulin IL-1R-related
molecule (SIGIRR) negatively regulate TLR signaling. IRAK M prevents the formation
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of IRAK1-TRAF complex by preventing dissociation of the MyD88-IRAK1-IRAK4
complex. SOCS1 proteins belong to E3 ubiquitin ligase and promote degradation of
TRAF proteins. MyD88s is a transcript variant of MyD88 and owing to its inability to
bind to IRAK4, prevents NF-κB activation. Regulation of gene expression through
transcription regulation is also employed in negatively regulating TLR induced gene
expression. miRNAs have emerged as a regulator of TLR signaling. miR-155, a TLR
induced miRNA can suppress and enhance TLR signaling. miRNAs have emerged as fine
tuners of TLR signaling (23, 44-46).
2.2.1.2 NLRs
Nucleotide-binding oligomerization domain (NOD) like receptors (NLRs) are
cytoplasmic proteins involved in recognition of intracellular bacteria. There are more
than 22 identified members of the NLR family in humans and more than 30 in mice. Two
most extensively studied NLR subgroup includes NLRC and NLRP. NLRC are NOD
proteins having N-terminal caspase recruitment domain (CARD), leucine rich repeats in
C-terminus and nucleotide binding domain in between. In NLRP subgroup, CARD is
substituted by Pyrin domain (47). NOD-1 and NOD-2 are two NOD proteins that
recognize two different peptidoglycan fragments and are involved in pathogen
recognition (48). Peptidoglycan (PGN) is a major constituent of gram-positive bacteria.
In gram negative bacteria PGN is covered by a thick layer of lipopolysaccharide (LPS).
PGN is composed of N-acetlyglucosamine (GlcNac) and N-acetylmuramic acid
(MurNac) linked by β-(1-4) linkage (49). PGN’s role in producing an inflammatory
response and stimulating immune response has been long known (50, 51). NOD1/CARD4 recognizes peptidoglycan GlcNAc-MurNAc-L-Ala-γ-D-Glu-meso-DAP (GM-
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TriDAP/iE-DAP) whereas NOD-2 recognizes muramyl dipeptide, MurNAc-L-AlaDisoGln. NOD-1 and NOD-2 activate NF-κB by recruitment of receptor-interacting serine/
threonine kinase (RICK) leading to secretion of pro-inflammatory cytokines while type I
interferons are secreted when IRF3/IRF7 dependent pathway is activated by these
receptors (52-56). NOD protein can function as a mediator of innate immunity itself and
also a modifier of innate immunity resulting from TLR stimulation (57).
2.2.1.3 RLRs
Retinoic acid inducible gene (RIG) like receptors (RLRs) are family of RNA
helicases. RLRs include RIG-I, melanoma differentiating gene 5 (MDA5) and recently
identified LGP2 (laboratory of genetics and physiology 2) proteins. Intracellular dsRNA
is sensed by RIG-I, MDA-5. RIG-I senses blunt ended 5’phosphorylated dsRNA whereas
MDA-5 recognizes long (>1000 nucleotide) dsRNA (58-60). Both RIG-I and MDA-5 are
RNA helicases that have caspase recruitment domain (CARD) and helicase domain.
Signal transduction after sensing of intracellular dsRNA is through CARD in both RIG-I
and MDA-5. This results in the activation of IRF-3 and NF-κB and subsequent
production of IFNs (type I, type III) and as well as pro-inflammatory cytokines like IL-6
and IL-8. LGP2 lacks CARD and is considered as a regulator of RIG-I and MDA-5
mediated immune response (61-65).
2.2.1.4 ALRs
Absent in melanoma protein 2 (AIM-2) is a member of a protein family called as
PYHIN (pyrin and HIN200 domain containing). AIM2 is associated with dsDNA (double
stranded DNA) induced inflammasome activation and interleukin-1β (IL-1β) production.
DNA in the cytoplasm either during viral replication or delivered by immune complexes
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binds to AIM2. AIM 2 is an interferon inducible protein as it can bind to apoptosis
related spec like protein (ASC) to form inflammasomes. Inflammasomes are multiprotein
complex that can induce pyroptosis (caspase 1 dependent programmed cell death as
means to combat intracellular pathogens by host cell) and pro-inflammatory cytokines
like IL-1β (17, 66-69).
2.2.1.5 OLRs
2ʹ–5ʹ-oligoadenylate synthase (OAS) is a protein group that senses cytosolic
dsRNA. Human OAS family consists of 4 IFN regulated genes OAS1, OAS2, OAS3, and
OASL. OAS1, OAS 2, and OAS 3 can recognize cytosolic dsRNA and synthesize 2ʹ–5ʹoligoadenylate synthase which in turn activates RNase L which binds and degrades viral
RNA. There is limited understanding of the mechanism of sensing dsRNA by OAS and
RNase L binding to dsRNA (70-72).
2.2.1.6 C-type lectin receptors (CLRs)
C-type lectin receptors (CLR) are transmembrane receptors that bind to
carbohydrates through carbohydrate binding domains (CRD). CLRs also include a
protein that does not recognize carbohydrate ligands but has structurally similar C-type
lectin domains (CTLDs). CLR activation can directly or indirectly induce intracellular
signaling. Lectins like dectin-2, macrophage-inducible C-type lectin (Mincle) indirectly
induce signaling by associating with immunoreceptor tyrosine-based activation motif
(ITAM) containing adaptor molecules. During direct induction of signaling CLRs like
Dectin 1 have ITAM like motif in the cytoplasmic region of the protein which they
employ to induce signaling. In both cases, phosphorylated spleen tyrosine kinases are
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recruited. A series of signaling steps lead to activation of NF-κB, mitogen associated
protein kinase (MAPK) which trigger cellular responses (73-75).
2.3 Cytokines
Cytokines are small non-structural proteins with molecular weight of 8-40,000
dalton. It is a biological function rather than consensus structural motif or amino acid
sequence that groups cytokines into a different class (76). Cytokine comprises of a range
of molecules that transmit intercellular signals. In the immune system, these orchestrate
immune function by involving in the generation of an inflammatory response and
restraining the inflammation (77, 78). Broadly the two major groups of cytokines are type
I and type II cytokines. Type I cytokines signal through type I cytokine receptor. Type I
cytokine have four α helical bundle and are further grouped into the short chain and long
chain. Type I short chain cytokines are 15 amino acids long while long chain cytokines
are 25 amino acid long. The IL-2 family of cytokine is grouped as short chain type I
cytokine. IFN (IFN-α/β/γ) and IL-10 are grouped as type II cytokines (77, 79, 80). Based
on immune function cytokines can be classified as pro-inflammatory and antiinflammatory cytokines.
2.3.1 Pro-inflammatory cytokines
Predominantly secreted by activated macrophages, pro-inflammatory cytokines
promote inflammation. These cytokines are also secreted by non-immune cells like
fibroblasts, intestinal epithelial cells and endothelial cells (81).
Interferons (IFN) are pro-inflammatory cytokines predominantly produced to
combat viral infections. There are three types of IFN, type I, type II, and type III. Type I
and type III are involved in antiviral response while type II is involved in regulation of
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immune responses. Type I IFN binds to heterodimeric signaling complex composed of a
single chain of IFNAR1 (IFN α/β receptor chain 1) and IFANR2 (IFN α/β receptor chain
2). Heterodimeric receptor complex for type I and type III IFN is present in almost all
nucleated cells. Type II IFN (IFN-γ) produced mainly by immune cells binds to the
tetrameric receptor complex composed of 2 subunits of IFNGR1 (IFN γ receptor 1) and
IFNGR2 (IFN γ receptor 2). Type I and type II IFN activate both common and distinct
STAT (signal transducer and activator of transcription) (82, 83).
Interleukin 1 was the first IL to be identified. Interleukin 1 (IL-1) family includes
cytokines like IL-1α, IL-1β, IL-18, IL-33, IL-36 α, β, and γ. Cytokines belonging to IL-1
family promote the activity of innate immune cells like neutrophils, eosinophils, natural
killer (NK) cells. IL-1 is an endogenous pyrogen that acts on hypothalamus-pituitary-axis
to induce fever. Elevated body temperature increases leukocyte migration. IL-1α
mediates early phase of sterile inflammation and the IL-1α precursor is fully functional.
Unlike IL-1α, IL-1β precursor requires caspase 1 cleaving to transform into active
cytokine. IL-1β is usually produced by hematopoietic cells, tissue macrophages, and
dendritic cells. IL-1α is produced by epithelial cells lining gut, lungs, liver etc. Although
both IL-1α and IL-1β act by binding to IL-1R1 (Interleukin 1 receptor 1), differences in
their function is due to the difference in the source of origin. IL-1α has an amino acid
sequence called nuclear localization sequence (NLS) that allows IL-1α to localize in the
nucleus and act as transcription component. IL-1β lacks NLS. IL-1 can activate
macrophages and epithelial cells and produce acute phase response (84, 85).
IL-6 is a pleiotropic cytokine and activates both T and B cells. It is mainly
produced by macrophages and endothelial cells. IL-6 binds to membrane bound IL-6
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receptor and associates with signaling glycoprotein gp130. Gp130 dimerization activates
Janus kinase and ultimately leads to activation of MAP kinase. While limited number of
cells express IL-6 R, an extensive number of cells express gp130. A soluble form of IL6R is generated into circulation to which IL-6 binds. This IL 6 bound receptor complex
can activate gp130 thus increasing the IL-6 spectrum. Apart from acute phase response
IL-6 promotes differentiation of naïve CD4+ T cells and thus links innate immune
response with the adaptive immune system (T-helper cells) (86-88).
Tumor necrosis factor-α (TNF-α) is produced as type II transmembrane protein
which is cleaved by TNF- α converting enzyme (TACE). TNF exerts biological function
by binding with membrane bound TNF receptor that has cysteine rich repeats in the
cytoplasmic domain. Cytokine of the TNF family exerts a biological effect by activation
of the NF-κB pathway (89). TNF-α is involved in the anti-tumor response, apoptosis, cell
survival and induction of inflammatory response (90). TNF- α is secreted by myeloid
cells, antigen presenting cells, stromal cells, epithelial cells and activated T cells (91).
IL-8 is a pro-inflammatory cytokine that belongs to CXC chemokine family. IL-8
is neutrophil activating peptide and IL-8 acts as a chemoattractant for neutrophils,
basophils and T cells. IL-8 acts through two receptors IL-8R A (CXCR1), and IL-8RB
(CXCR2) (92, 93).
2.3.2 Anti-inflammatory cytokines
Anti-inflammatory cytokines are immune regulatory cytokines that check
responses of pro-inflammatory cytokines. IL-1R antagonists, IL-4, IL-10, IL-11, IL-13 all
act as anti-inflammatory cytokines (94).
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IL-10 is an anti-inflammatory cytokine structurally related to IFN. Dysregulation
of IL-10 leads to autoimmune disorders and immunopathies. Initially described as a
cytokine produced from Th2 cells to check cytokine synthesis of Th1 cells, recent reports
suggest that macrophages, dendritic cells also produce IL-10. IL-10 inhibits B7-1/B7-2
expression on monocyte and macrophages. B7-1/B7-2 are co-stimulatory molecules that
activate CD4+ T cells. IL-10 also inhibits secretion of pro-inflammatory cytokines and
chemokines. IL-10 can thus limit T cell activation, inhibit production of proinflammatory cytokines and affect Th1 and Th2 responses (95-97).
2.4 Innate immune response at gastro-intestinal tract
Gastro-intestinal (GI) tract harbors largest number of microbiota as well as the
largest number of immune cells for a given tissue. Gut microbiota educates immune cells
and is essential for the development of a robust immune system. The host, in turn, needs
to mount an effective immune response against invading pathogens and tolerance against
commensals and food antigens. Thus, regulatory mechanism and barrier function of the
GI tract is of utmost importance for appropriate host microbe interaction and
homeostasis. A key to achieving this dynamic interaction is to segregate host tissue from
gut microbiota. Intestinal epithelial cells (IECs) maintain homeostasis by providing a
physical barrier and by sensing and responding to microbial stimuli (98-100).
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Fig 3: Schematic representation of the Intestinal Epithelial cell barrier. Adapted from
(100).
GI tract is divided into four layers; mucosa, submucosa, muscularis propria, and
serosa. Mucosa is the innermost layer and consists of epithelium, lamina propria, and
muscular mucosae. Muscularis propria consists of an inner circular muscle layer and the
outer longitudinal muscle layer.
The epithelium consists of different cell lineages originating from common stem
cell progenitor. The epithelial layer is organized into crypts and villi. Pluripotent
intestinal epithelial stem cells reside at crypts base. Enterocytes are most abundant cells
in the intestinal epithelial layer and are involved in absorption of nutrients. Specialized
secretory IECs are goblet cells that produce mucus, enteroendocrine cells that produce
hormones, and Paneth cells that produce antimicrobial peptides like defensins. M cells
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(microfold cells) lack villi and are involved in transcytosis of antigen and thus help in
antigen sampling (101, 102). Recent reports suggest that M cells can uptake specific
antigen by using surface glycoprotein receptor. Thus M cells are capable of both specific
and non-specific antigen uptake from intestinal lumen (103).
Mucin secreted from goblet cells acts as the first line of defense. Mucin deficient
mouse develops colitis (104). Paneth cells are concentrated in the ileum and produce
antimicrobial peptides like lysozymes, defensins, regenerating islet-derived protein-IIIγ
(REGIIIγ). RegIIIγ is involved in host-microbial segregation in GI tract (105). Sensing of
PAMPs by PRRs expressed in intestinal mucosa helps to mount an effective innate
immune response against pathogens and induce tolerance to commensals. Such PRRs are
expressed by intestinal epithelial cells and by mesenchymal cells like intestinal subepithelial myofibroblasts (ISEMFs). Unlike other body sites, IECs in intestine express
PRRs that are involved in altered responsiveness. PRRs in other body sites are associated
with induction of inflammatory response upon sensing of PAMPs. In intestine where the
majority of microbes are commensals, PRRs are involved in dampening of immune
response and maintaining tissue homeostasis (106, 107).
IECs express polymeric immunoglobulin receptor (pIgR). Secretory IgA (sIgA)
produced by plasma cells binds to pIgR and this sIgA-pIgR complex is transcytosed to
intestinal lumen. sIgA is essential to maintain intestinal homeostasis. Gut associated
lymphoid tissue (GALT) and draining lymph nodes are essential for adaptive immune
responses. These GALT are also part of the mucosal immune system. GALT consists of
isolated lymphoid follicles or aggregated lymphoid follicles that collectively form
Payer’s Patches. These sub-epithelial lymphoid aggregates reside in mucosa or
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submucosa. Follicle associated epithelium lies above these lymphoid aggregates. One of
the follicles associated epithelium is M cell. Sub-epithelial dome region is rich in
dendritic cells and dendritic cell processes antigens after transcytosis by M cells. Solitary
isolated lymphoid follicles (SILT) are microscopic lymphoid aggregates which can range
from cryptopatches to isolated lymphoid follicles (ILF). NOD1 signaling in stromal cells
promotes intestinal SILT maturation (99, 100, 108).
Intestinal sub-epithelial myofibroblasts (ISEMFs) are mesenchymal cells residing
beneath the intestinal mucosa (109-111). They also regulate the behavior of intestinal
stem cells through intracellular mechanisms like Wnt, Bmp, Notch (5). ISEMF cells have
been characterized as nonprofessional immune cells (112). They are also reported to be
involved in the induction of peripheral tolerance in intestinal mucosa primarily through
programmed death ligand-1 (PD-L1) mediated suppression of CD4+ T cell activity (113,
114).
GI tract is involved in both induction of immune response and maintenance of
tolerance by identifying pathogens from commensals microbes. This complex task
requires complex interplay between the mucosal barrier and immune cells. Intestinal
epithelial cells and intestinal sub-epithelial myofibroblasts by expression of PRRs mount
selective immune responses and are key players of intestinal innate immune responses.
2.5 RT-qPCR
Polymerase chain reaction (PCR) is a revolutionary concept developed by Karry
Mullis in 1980. The enzyme DNA polymerase adds nucleotides (dideoxynucleotides;
dnTPs) complementary to given template. Since DNA polymerase can add nucleotide
only to 3’-OH group, it requires short nucleotide sequences called primer sequence.
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Changes in temperature allow for control over polymerase activity and primer binding.
Conventional PCR could only detect the presence of a specific gene. Conventional PCR
could not infer relative abundance of a gene in two samples. To overcome this,
fluorescence-based chemistry was developed called as real time-PCR or quantitative PCR
(qPCR). qPCR can obtain amplification data in real time. If complementary DNA
produced by reverse transcribing of mRNA is used as a template for PCR, it is called as
reverse transcriptase PCR. Fluorescence based real time reverse transcriptase PCR allows
for quantification of steady state mRNA expression. SYBR green based qPCR is one of
the widely used fluorescence-based PCR assay. SYBR green dye is a fluorescent dye that
binds to double stranded DNA only. Fluorescence occurs only if SYBR green dye is
bound to double stranded DNA. As the amplification occurs, fluorescence increases as
more double stranded DNA are being formed. A sensor collects all the data which is
expressed in terms of Ct (threshold cycle) values. Ct value is the number of PCR cycles
required by fluorescent signal to overcome background signal. A lower Ct value indicates
stronger gene expression. Since SYBR green dye can bind to any dsDNA, the specificity
of the data is validated using a dissociation curve or melting curve. A dissociation curve
is obtained at end of PCR process by first denaturing all products followed by annealing
and dissociation. The first derivative of the dissociation curve assesses the homogeneity
of the PCR product. Two major quantification approaches are employed for qPCR data.
For absolute quantification, a standard curve using serial dilution of known RNA
concentration or copy number is plotted against Ct values. Ct value of the unknown
sample for the gene of interest is used to assess concentration using standard curve. In
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relative quantification, sample Ct values are normalized against the reference genes (115,
116).
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Chapter 3. Development and characterization of a stable bovine intestinal subepithelial myofibroblast cell line from ileum of a young calf.

Abstract
Intestinal sub-epithelial myofibroblasts (ISEMFs) are mesenchymal cells that do
not express cytokeratin but express α-smooth muscle actin and vimentin. Despite being
cells with diverse functions there is a paucity of knowledge about their origin and
functions primarily due to the absence of a stable cell line. Although myofibroblast invitro models for humans, mouse, and pig are available, there is no ISEMF cell line
available from young calves. We isolated and developed an ileal ISEMF cell line from a
2-day old calf that expressed α-smooth muscle actin and vimentin but no cytokeratin
indicating true myofibroblast cells. To overcome replicative senescence, we immortalized
primary cells with SV40 large T antigen. We characterized and compared both primary
and immortalized ileal ISEMF cells for surface glycan and Toll-like-receptors (TLRs)
expression by lectin binding assay and real time-quantitative PCR (RT-qPCR) assay
respectively. SV40 immortalization significantly decreased surface lectin binding for
lectins GSL-I, PHA-L, ECL, Jacalin, Con-A, LCA, and LEL. Both cell types expressed
TLR 1-9 and showed no significant differences in TLR expression. Thus, these cells can
be useful in-vitro model to study ISEMF’s origin, physiology, and functions.

Keywords: intestinal sub-epithelial myofibroblast, bovine, lectin, toll-like receptors.
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3.1 Introduction
Intestinal sub-epithelial myofibroblasts are mesenchymal cells residing beneath
the intestinal mucosa (109-111). Originally described by Kaye et al in 1968 (117) and
later termed as myofibroblasts by Majno et al in 1971 (118), these cells have gained
widespread interest due to their diverse functions ranging from wound healing (119),
promotion of tumor progression (120), to their role in inflammatory bowel disease (IBD)
(121). ISEMFs are important in the regulation of barrier function of the intestinal
mucosa. They play a pivotal role in the development of the mucosal layer as they are
involved in morphogenesis and cytodifferentiation of the intestinal mucosa (109, 110).
Epimorphin/syntaxin 2, a mesenchymal protein expressed by ISEMF cells promotes
morphogenesis of villi (122) and ISEMFs are also involved in restitution and
differentiation of the epithelium by secreting stem cell factors, growth factors like
transforming growth factor- β3 (TGF-β3), and amphiregulin (123, 124). They also
regulate the behavior of intestinal stem cells through intracellular mechanisms like Wnt,
bone morphogentic protein (Bmp), and Notch signaling (5). ISEMF cells have been
characterized as nonprofessional immune cells (112) and nonprofessional antigen
presenting cells (125). They also express Toll like receptors (TLRs) but their response to
pathogen associated molecular patterns (PAMPs) have not been elucidated (126).
Myofibroblasts have characteristics intermediate between a fibroblast cell and a
smooth muscle cell (111, 127). They are characterized mainly by the presence of alphasmooth muscle actin (α-SMA) (123, 128) along with vimentin and negative to weak
staining for desmin (112, 120, 129). Myofibroblast cell morphology transitions from
discoid or polygonal to elongated with an increase in cell passage (111).
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Limited understanding of ISEMFs owing to un-availability of stable ISEMF cell
line has impeded studies on this cell type. Only a single bovine ISEMF cell culture study
has been reported till date (130) and most of the other cell lines are either from rat (131133), mouse (126, 134) or humans (5). In this study, we established and characterized a
stable ileal ISEMF cell line from the 2-day old calf that demonstrates characteristics
peculiar to myofibroblast cells.
3.2 Materials and Methods
3.2.1 Establishment of primary ileal ISEMF cell culture
An animal protocol for the use of a calf for cell line development was approved
by SDSU Institutional Animal Care and Use Committee (IACUC). Ileum from 2-day old,
colostrum deprived Holstein male calf, was collected in supplemented Hanks Balanced
Salt Solution (HBSS containing 1% streptomycin-penicillin, 5ug/ml of gentamycin, 2
mM of L-glutamine). The lumen was washed two times with warm phosphate buffered
saline (PBS). Both ends of the ileal loop were ligated with silk suture after flushing the
lumen with supplemented HBSS (HBSS-S). Lumen was filled with phosphate buffered
saline (PBS) containing 1 mM dithiothreitol and incubated for 5-10 minutes in a water
bath at 370 C with constant shaking to remove mucus. To digest the intestinal tissue,
loops were filled with warm (370 C) HBSS-S containing 300 units/ml of collagenase-type
II (catalog number LS004176, Worthington Biochemical 130 Corporation, NJ, USA) and
0.24 units/ml of dispase (catalog number 50-100- 131 3345, Roche Diagnostics, IN,
USA), and incubated at 370 C in water bath with constant shaking for 15 minutes. The
contents were discarded and the process of digestion with collagenase and dispase was
repeated, but incubation time was increased from 15 minutes to 45 minutes. The content
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thus obtained were also discarded. The predigested epithelium and sub-epithelium were
scraped with sterile scalpel blade after longitudinally opening the ileal loop. The contents
thus obtained were incubated in HBSS containing 2.4 U/ml of dispase for 10 minutes and
then centrifuged at 140 g for 3 minutes. The pellet was resuspended in 30 ml of DMEM
(Dulbecco’s modified eagle media) containing 2% sorbitol and centrifuged at 50 g for 3
minutes. The supernatant was collected and grown in T-75 flask containing DMEM-10
media. DMEM-10 media contained DMEM, 10 % fetal calf serum, 1 % non-essential
amino acids, and 1 % penicillin-streptomycin. The cells attached and started showing
myofibroblast like morphology and retained myofibroblast like morphology even at later
passages when observed under Olympus IX70 phase contrast microscope.
3.2.2 Generation of SV40 immortalized ISEMF cell line.
Passage 20, 0.5 X 106 ISEMF cells were seeded into 3 wells of a 6-well tissue
culture plate. Cells in the first well were kept as such. Cells on the second well were used
for negative control, and cells in the third well were used for transfection with pSV3-neo
plasmid (ATCC® 37150) vector containing SV40 Large T Antigen gene. For
transfection, Lipofectamine® 2000 (catalog number 11668-027, Invitrogen, Carlsbad,
CA) reagent and manufacturer’s protocol were used. The lipofectamine-plasmid
complex was added on to cells in the third well whereas only lipofectamine was added in
cells on the second well. All three wells were incubated with serum-free OPTI-MEM®
media for 12 hours followed by washing with 1X PBS. Cells were then grown in
selection antibiotic G418 (catalog number 10131-035, Thermo Fisher, Waltham, MA,
USA) for 7 days at a concentration of 2500 µg/ml of media. After antibiotic selection
cells were grown on fibroblast media containing 500 µg/ml of G418 antibiotic.
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3.2.3 Immunocytochemical (ICC) staining of primary and SV40 immortalized
ISEMF cells
Monoclonal antibodies (mAbs) specific against epithelial, fibroblast, and smooth
muscle cell markers were used to stain primary and SV40 immortalized cells using the
protocol as described previously (135, 136). Briefly, cells cultured in T-25 or T-75 flasks
were trypsinized using 0.05% of Trypsin EDTA (Corning®, reference number 25-052CV) and counted using hemocytometer to prepare 106 cells/ml suspension of primary
ileal ISEMFs and SV40 immortalized ileal ISEMFs. Hundred microliter of cell
suspension was used to prepare cytospins using a cytofuge (Cytospin 3; Thermo Shandon
Inc. Pittsburgh, PA, USA). After air drying for 2 hours, the cytospins were fixed in
acetone for 7 minutes. Slides were then washed with 1% PBS. Endogenous peroxidase
was blocked by 7 minutes incubation of slides in blocking solution (0.3% hydrogen
peroxide and 0.01% Sodium azide in PBS). To prevent further non-specific antibody
binding, if any, slides were incubated with 1% goat serum for 20 minutes. An avidinbiotin blocking kit (catalog number SP2001, Vector Laboratories, Burlingame, CA, USA)
was used to block endogenous biotin. Specific mAbs were used to detect the presence of
cytokeratin, α-smooth muscle actin (α-SMA), desmin and vimentin proteins by
immunocytochemistry. Anti-cytokeratin mAb (mAb) C6909 (IgG2a isotype), antivimentin mAb V5255 (IgM isotype), anti-alpha smooth muscle actin mAb A2547
(IgG2a) and anti-desmin mAb D1033 (IgG1) were used. Isotype-matched controls, mAbs
M9269 (IgG1 isotype), M9144 (IgG2a isotype) and 196 M5170 (IgM isotype) were also
used. Cells incubated with PBS alone served as negative control. All primary and isotype
control mAbs were bought from Sigma-Aldrich (Sigma-Aldrich, St. Louis-MO). Slides
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were incubated for an hour with 100 µl (1 µg/ml) of the specific primary antibody or
isotype controls. Slides were then washed and incubated with 100 µl (1:2000 dilution) of
isotype-specific, biotinylated goat-anti mouse IgG2a, IgG1, and IgM antisera (Caltag
Laboratories) for 30 minutes. Presence of specific protein in the ISEMFs was detected by
incubating slides with the HRP-streptavidin solution for 30 min, followed by ready-to-use
(RTU) diaminobenzene (DAB) substrate (Vector Laboratories, Burlingame, CA, USA).
Hematoxylin was used as a nuclear stain. Images were taken with an Olympus BX53
upright microscope at 20X magnification.
3.2.4 Confirmation of SV40 immortalization by PCR
Genomic DNA from the primary (passage 22) and SV40 immortalized ISEMF
cells (passage 22) was extracted using DNeasy Blood & Tissue Kit (Catalogue number
69504, Qiagen, Valencia, CA, USA). DNA concentration was quantified using Nanodrop
2000 (Thermo scientific). Hundred nanograms each of genomic DNA extracted from
primary ISEMFs, SV40 immortalized ISEMFs, and pSV3-neo plasmid containing SV40
Large T Antigen gene were used to amplify SV40 gene using gene specific primers
(Table 2) previously used by others (137). To amplify the gene of interest, we amplified
the genomic DNA and pure plasmid using PCR. Taq PCR kit (catalog number E5000S,
New England Biolabs, Ipswich, MA, USA) was used for PCR assay. The thermal profile
used for PCR was; initial denaturation at 950C for 5 minutes, followed by 30 cycles of
annealing and extension at 950C for 30 seconds, 550C for 60 seconds, 720C for 60
seconds, and the final extension at 720C for 10 minutes. The amplicons were resolved in
2% agarose gel by running it at 85 volts for 45 minutes.
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Table 2: Primer Sequences used for amplification of SV40 gene in ISEMF cells
Gene

SV40

Primer sequence

Forward:

Product

Tm

size (bp)

(0C)

751

55

5′-AGCAGACACTCTATGCCTGTGTGGAGTAAG-3′
Reverse:
5′-GACTTTGGAGGCTTCTGGATGCAACTGAG-3′

3.2.5 Confirmation of SV40 immortalization by indirect immunofluorescence assay
Indirect immunofluorescence assay was also performed to further confirm the
presence of SV40 protein in immortalized cells. Twenty-five thousand primary ISEMFs
(passage 17) and SV40 immortalized ISEMF cells (passage 38, 18 passage after
immortalization) were cultured in the chambered slide. For each cell type, two chambers
were used, the first chamber for isotype control and second for confirmation of
immortalization. After 24 hours, the cells in the slide were washed with 1X PBS, fixed
and permeabilized using acetone and methanol mix (1:1, 250 µL/chamber) and incubated
at -200C for 10 minutes. Cells were washed again with PBS, blocked for non-specific
protein binding by incubating for 20 minutes at room temperature after addition of
blocking solution (1% goat serum in 0.2% Triton X and 1% PBS). Cells were washed
again and 250 ul (4ug/ml concentration) of either mouse IgG2a isotype control (mAb
M9144, Sigma, St. Louis, MO, USA) or mouse anti-SV40 specific monoclonal IgG2a
antibody (Santa Cruz Biotechnology, Dallas, TX, USA; sc-53488) was added on
respective chambers. Cells were then incubated at 370C for an hour. After washing with
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PBS, Alexa Fluor 488 conjugated goat anti-mouse IgG secondary antibody (1:200
dilutions, Invitrogen, USA, A-11001) was added and incubated in dark at 370C for an
hour. Cells were washed with PBS, equilibrated by addition of 2X saline sodium citrate
(SSC) buffer for 5 minutes followed by washing with PBS. Then, 250 µl of propidium
iodide (1uM, 1:1,000 dilution) was added and incubated for 5 minutes for nuclear
staining of cells. Cells were then washed and mounted using permaflour mounting
reagent. Images were taken using an Olympus BX53 upright microscope at 20X
magnification.
3.2.6 Lectin Binding Assay:
The binding profile of 23 different lectins (Table 3) was identified in both primary
and SV40 immortalized ISEMFs as per manufacturer’s (Vector Laboratories,
Burlingame, CA, USA) protocol. As per the protocol, cells were trypsinized and counted.
Approximately 0.5X106 cells were transferred to 96-well U bottom plate. Cells were
incubated for an hour at 40C with 100 µl of 10 µg/ml of specific biotinylated lectins. To
show specificity of lectin binding, another well with the same number of cells was
incubated with a same volume and concentration of lectin and its specific inhibitor
solution. Cells were then washed three times with 1X PBS and centrifuged to pellet the
cells. Cells were then incubated in dark with 5 µg/ml of streptavidin-FITC (1:200
dilutions) at 40C for 30 minutes. Cells were then washed and resuspended in 200 µl of
1% paraformaldehyde. For each assay, a separate well containing cells and streptavidinFITC was included as negative control. The percentage of cells staining with lectins was
measured using FACS Calibur cytometer (Becton Dickinson, San Jose, CA, USA).
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Primary ISEMF cells from passage 15-27 and SV40 immortalized ISEMF from passage
40 (20 after immortalization)- passage 47 (27 after immortalization) were used.

Table 3: Lectins and lectin inhibitors used for studying glycobiology of ISEMF cells
Lectins

Binding

Inhibitors

Inhibitor

Specificity of

concentration

Lectins

(mM)

1. Glucose/Mannose
group
Canavalia ensiformis

α-Man,

α-methyl mannoside,

agglutinin (Con-A)

α-Glc

α-methyl glucoside

Pisum Sativum

α-Man,

α-methyl mannoside,

agglutinin (PSA)

α-Glc

α-methyl glucoside

Lens culinaris

α-Man,

α-methyl mannoside,

agglutinin (LCA)

α-Glc

α-methyl glucoside

200 mM each

200 mM each

200 mM each

2. Nacteylgalactasomine
group
Griffonia simplicifolia
lectin I (GSL-1)
Soybean (Glycine

α-GalNAc,

Galactose

200 mM

α-GalNAc,

N-acetylgalactosamine

100 mM

α-GalNAc,

N-acetylgalactosamine

100 mM

β-GalNAc,

Galactose

200 mM

N-acetylgalactosamine

100 mM

α-Gal

maxi) agglutinin (SBA)
Dolichohs biflorus
agglutinin (DBA)
Ricinus communis
agglutinin (RCA-120)
Sophora japonica
agglutinin (SJA)

β -Gal
β-GalNAc,
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β-GalNAc,

N-acetylgalactosamine

100 mM

β-GlcNAc

Chitin hydrosylate

200 mM

β-GlcNAc

Chitin hydrosylate

200 mM

β-GlcNAc

Chitin hydrosylate

200 mM

β-GlcNAc

Chitin hydrosylate

200 mM

α, β-GlcNAc

Chitin hydrosylate

200 mM

β-GlcNAc

Chitin hydrosylate

200 mM

β -Gal

Chitin hydrosylate

200 mM

Erythrina cristagalli

β -Gal,

Lactose

200 mM

lectin (ECL)

β-GalNAc

Artocarpus integrifolia

β -Gal

Galactose

400 mM

Α-Fuc

No Inhibitor used

Vicia villosa agglutinin
(VVA)
3. Nacetylglucosamine
group
Lycopersicon
esculentum (tomato)
lectin (LEL)
Solanum tuberosum
(potato) lectin (STL)
Wheat (Triticum
vulgaris) germ
agglutinin (WGA)
Datura stramonium
lectin (DSL)
Griffornia simplicifolia
lectin II (GSL-2)
Succinylated WGA
(SWGA)
Peanut (Arachis
hypogaea) agglutinin
(PNA)

(Jacalin)
4. Fucose group
Ulex europaeus
agglutinin I (UEA-1)
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5. Oligosaccharide
group
Phaseolus vulgaris

Oligosaccharide

No Inhibitor used

Oligosaccharide

No Inhibitor used

erythroagglutinin
(PHA-E)
Phaseolus vulgaris
Leucoagglutinin (PHAL)
6. Sialic acid group
Sambucus nigra lectin

NeuAcα(2,6)Gal Lactose

200 mM

NeuAcα(2,3)Gal N-acetylneuraminic acid

200 mM

(SNA)
Maackia amurensis
lectin II (MAL-II)

(NANA)

3.2.7 Analysis of TLR expression in primary ISEMF and SV40 immortalized
ISEMF by RT-qPCR
For analysis of TLR expression by primary and SV40 immortalized ISEMF cells,
we used SYBR-green based real time-quantitative polymerase chain reaction (RT-qPCR)
assay. RNA was extracted from cells using RNeasy Mini Kit (catalog number 74101,
Qiagen, Valencia, CA, USA). RNA was quantified using Thermo Scientific™ NanoDrop
2000. One microgram of RNA was reverse transcribed to cDNA using TaqMan reverse
transcription kit and kit protocol (TaqMan reverse transcription reagents, Applied
Biosystems, catalog number N8080234). For RT-qPCR 2 µl of diluted cDNA (1:5
dilution), 1 µl each of forward and reverse primer (10 µM stock), 10 µl of RT² SYBR®
Green/ROX qPCR mastermix (catalog number 330501, Qiagen, Valencia, CA, USA) and
6 µl of nuclease free water were added. The thermal profile used for amplification was: 2
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minutes at 500C; 10 minutes at 950C; followed by 40 cycles of 45 seconds at 950C, 30
seconds at 600C and 30 seconds at 720C. Ramping speed was set at 1.60C/second.
QuantStudio™ 6 Flex Real-Time PCR System (Applied Biosystems, NJ, USA) was used.
Data were normalized using the housekeeping gene (Cyclophillin-A). Primer sequences
previously used (138) for amplification of TLR 1-9 gene and Cyclophillin-A as
housekeeping gene (139) are listed in Table 4. Primary ISEMF cells from passage 15-20
and SV40 immortalized cells from passage 33 (13 passage after immortalization) to
passage 35 (15 passage after immortalization) were used for comparing TLR expression.
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Table 4: Primer sequences of genes along with gene bank accession number used in
analysis of TLRs expression of ISEMF cells
Forward primer

Reverse primer

Accession
number

TLR 1

TLR 2

TLR 3

TLR 4

TLR 5

TLR 6

TLR 7

TLR 8

TLR 9

CAT TCC TAG CAG CTA

TGG GCC ATT CCA AAT

NM_001046

CCA CAA GCT

AAG TTC T

504

GGG TGC TGT GTC ACC

GCC ACG CCC ACA TCA

NM_174197

GTT TC

TCT

GGG CAC CTG GAG GTC TTC CTG GCC TGT GAG

NM_001008

CTT

TTC TTG

664

AGC ACC TAT GAT GCC

GTT CAT TCC GCA CCC

NM_174198

TTT GTC A

AGT CT

GTC CCC AAC ACC ACC

GCG GTT GTG ACT GTC

NM_001040

AAG AG

CTG ATA TAG

501

TTT ACC CTC AAC CAC

GGG CCA AAG GAA CTG

NM_001001

GTG GAA

AAA AAC

159

CAC CAA CCT TAC CCT

GTC CAG CCG GTG AAA

NM_001033

CAC CAT T

GGA

761

TGT GTT TAG AGG AAA

TCT GCA TGA GGT TGT

NM_001033

GGG ATT GG

CGA TGA

937

CAG TGG CCA GGG

CCG GTT ATA GAA GTG

NM_183081

TAG TTT CTG

ACG GTT GT

Cyclophilin-A CTTTCACAGAATAATTC CAGTACCATTATGGCGTG
CGGGATT

BC105173

TGAAG

3.2.8 Statistical Analysis:
For comparison of differences in lectin binding between primary and SV40
immortalized ISEMFs, two tailed two sample unequal variance t-test was used. A p-value
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of less than 0.05 (p<0.05) was considered significant. For analysis of TLR expression in
primary ISEMF, Ct values for TLR genes were normalized with housekeeping gene. The
result was expressed as delta Ct (ΔCt). A lower ΔCt means stronger gene expression. A
non-parametric test (Mann-Whitney U test) was used to compare normalized Ct (∆Ct)
values (136). Mann-Whitney U test was applied using GraphPad Prism 7.04.
3.3 Results
3.3.1 Immunocytochemical (ICC) staining of primary and SV40 immortalized
ISEMF cells
The primary ileal ISEMF cells were cultured up to 27 passages without any
changes in their morphological characteristics. SV40 immortalized ISEMF cells were
passaged up to 20 passage after immortalization and were stocked after this passage.
Cells obtained after scrapping of enzymatically digested ileal tissue in culture started
showing stellate to spindle shape typical of myofibroblast cells (Fig 4).
Immunocytochemical (ICC) characterization of primary ISEMF (Figure 5) and SV40
immortalized ISEMF (Fig 6) cells showed positive staining for α-SMA (Fig 5C, and 6C)
and vimentin (Fig 5B, and 6B), weak staining for desmin (Fig 5D, and 6D), and no
staining for cytokeratin (Fig 5A and 6A). A weak staining indicates few cells expressing
the markers while negative staining indicates complete absence of staining. The
specificity of staining was demonstrated by negatively stained isotype contol for each
marker.
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Fig 4: Phase contrast image of primary and SV40 immortalized ISEMF cells. A. Phase
contrast image of primary ISEMF cells (cells obtained and cultured after scrapping of
enzymatically digested ileal tissue). B. Phase contrast image of primary ISEMF cells
(passage 1). C Phase contrast image of primary ISEMF cells (passage 15). D. Phase
contrast image of SV40 immortalized ISEMF cells (passage 39, 19 passage after
immortalization). Scale bar represents 100 µm for image A and 50 µm for rest of the
images.
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Fig 5: Immunocytochemistry of primary ISEMF cells. Images on right are specific
isotypes, and images on left are for cell specific markers. Brown pigmented cells indicate
positive staining A. IgG2a isotype control, and anti-cytokeratin-IgG2a Ab staining. B.
IgM isotype control, and anti-vimentin-IgM-Ab. C. IgG2a-isotype control, and anti-αSMA-IgG2a antibody. D. IgG1 isotype control, and anti-desmin- α-SMA-IgG2a
antibody. Cells stained positive for α-SMA, and vimentin, weakly stained for desmin, and
negative for cytokeratin. The scale bar at the bottom right of figure represents 50 µm
length. Images are representative of 3 independent experiments.
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Fig 6: Immunocytochemistry of SV40 immortalized ISEMF cells. Images on right are
specific isotype controls, and images on left are for cell specific markers. Brown
pigmented cells indicate positive staining A. IgG2a isotype control, and anti-cytokeratinIgG2a Ab staining. B. IgM isotype control, and anti-vimentin-IgM-Ab. C. IgG2a-isotype
control, and anti-α-SMA-IgG2a antibody. D. IgG1 isotype control, and anti-desmin- αSMA-IgG2a antibody. Cells stained positive for α-SMA, and vimentin, weakly stained
for desmin, and negative for cytokeratin. The scale bar at the bottom right represents 50
µm length. Images are representative of 3 independent experiments.
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3.3.2 Generation of SV40 immortalized ISEMF cells and confirmation of
immortalization
After transfection of primary ISEMF cells with pSV3-neo plasmid, antibiotic
selection with G418 resulted in SV40 immortalized ISEMF cells. To confirm the
presence of the SV40 large T antigen gene, conventional PCR was performed, and
product was resolved in 2 % agarose gel. Gel imaging confirmed the presence of the gene
of interest in SV40 immortalized ISEMF cells (Fig 7), with pSV3-neo plasmid and SV40
immortalized ISEMF showing same amplified product size (751 bp) when amplified for
SV40 large T antigen gene. Phase contrast microscopy showed SV40 immortalized
ISEMFs cell resembled primary myofibroblasts in culture (Fig 4B).
An indirect immunofluorescence assay confirmed the presence of SV40 large T
antigen protein in SV40 immortalized cells (Fig 8L). Isotype control and primary cells
did not show fluorescence when stained with Alexa fluor-488 conjugated anti-SV40 large
T antigen-IgG2a antibody (Fig 8C, 8F, and 8I).
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Fig 7: Gel image showing the presence of SV40 large T antigen gene in SV40
immortalized ISEMF cells. Lane 1 shows 2 log DNA ladder. Lane 2 shows pSV3-neo
plasmid. Lane 3 shows SV40 large T antigen gene in SV40 immortalized ISEMF cells.
Lane 4 shows absence of SV40 gene in primary ISEMF cells. Lane 5 shows no template
control. The size of the amplified product is 751bp.
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Fig 8: Immunofluorescence assay to confirm the presence of SV40 large T antigen
protein in SV40 immortalized ISEMF cells. A. Primary ISEMF cells with isotype control.
B. Primary ISEMF cells nuclear staining C. Composite image of A and B. D. Primary
ISEMF cells with SV40 specific mAb and Alexa 488 conjugated secondary antibody. E.
Primary ISEMF cells nuclear staining. F. Composite image of D and E. G. SV40
immortalized ISEMF cells isotype control. H. SV40 immortalized ISEMF cell nuclear
staining I. Composite image of G and H. J. SV40 immortalized ISEMF cells with SV40
specific mAb and Alexa 488 conjugated secondary antibody. K. Primary ISEMF cells
nuclear staining. L. Composite image of J and K. Images are representative of three
experiments. Scale bar at bottom right represents 50 µm.
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3.3.3 Lectin Binding assay
Out of 23 different lectins DBA, SJA, VVA, GSL-II, PSA, and UEA-I did not
stain, or extremely low percentage of cells stained for these lectins in both cell types
(primary and immortalized cells). Lectins RCA-120, LEL, GSL-I, STL, PHA-E, and
PHA-L showed higher cell percentage of stained cells (>80%) in both cell types (Fig 9,
and Fig 10). SV40 immortalization significantly decreased the percentage of cells
staining for GSL-I ( 92.7± 1.17 for primary ISEMFs to 83.29± 2.07) for SV40
immortalized ISEMFs), LEL (91.44±5.4 for primary ISEMFs to 73.7± 6.19 for SV40
immortalized ISEMFs) and PHA-L (89.54±0.85 for primary ISEMFs to 72.02±5.82 for
SV40 immortalized ISEMFs), Jacalin (62.18±11.72 for primary ISEMFs to 17.3±4.55 for
SV40 immortalized ISEMFs), ECL (56.32±7.05 for primary ISEMFs to 18.09±5.4 for
SV40 immortalized ISEMFs), Con-A (38.94±8.4 for primary ISEMFs to 4.65±2.4 for
SV40 immortalized ISEMFs), and LCA (73.7±10.91 for primary ISEMFs to 24.34±8.2
for SV40 immortalized ISEMFs) (Figure 11). Most of the inhibitors reduced the
percentage of cell stained for specific lectins in both primary and SV40 immortalized
cells (Figure 9 and 10). For SNA, the inhibitor reduced the percentage of stained cells,
but it was not a complete inhibition.
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Lectins

80

Inhibitors

60
40
20
0

SBA
DBA
SJA
VVA
RCA-120
GSL-I
GSL-II
DSL
LEL
STL
WGA
SWGA
PNA
Jacalin
ECL
Con-A
PSA
LCA
UEA-I
MAL-II
SNA
PHA-E
PHA-L

Percentage of cells stained

100

Lectins

Fig 9: Lectin binding profile for primary ISEMF cells. Black bars show the percentage of
cells staining for specific lectins and grey bars show inhibition of staining by specific
inhibitors. Results are mean of three different experiments with error bars representing
standard error of the mean (SEM).
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Fig 10: Lectin binding profile for SV40 immortalized ISEMF cells. Black bars show the
percentage of cells stained for specific lectins and grey bars show inhibition of staining
by specific inhibitors. Results are mean of three different experiments with error bars
representing standard error of the mean (SEM).
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Fig 11: Comparison between primary and SV40 immortalized ISEMF for the percentage
of cells stained for a given lectin. Significant differences in the percentage of cells stained
for given lectin after immortalization are denoted by an asterisk (*). Results are mean of
three different experiments with error bars representing standard error of the mean
(SEM).
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3.3.4 Analysis of TLR expression in primary ISEMF and SV40 immortalized
ISEMF cells by RT-qPCR
Normalized Ct values (∆Ct) for primary and SV40 immortalized ISEMFs were
analyzed for any differences using Mann-Whitey U test. The test showed no significant
differences in TLR expression after immortalization (Figure 12). The Ct values for
housekeeping gene Cyclophillin-A ranged from 19.15-20.18 for primary ISEMF cells,
and 22.09-22.39 for SV40 immortalized ISEMF cells. All 9 TLRs (TLR 1-9) were
expressed by both primary and SV 40 immortalized ISEMF. TLR 2, 3, 4 had a relatively
stronger expression (Figure 12) than other TLRs in both cell types.

54

15

P r im a r y IS E M F
S V 4 0 - IS E M F

 Ct

10

5

T LR 9

T LR 8

T LR 7

T LR 6

T LR 5

T LR 4

T LR 3

T LR 2

T LR 1

0

TLRs

Fig 12: TLR 1-9 expression in primary and SV40 immortalized ISEMF cells represented
by normalized Ct values (normalized against the Ct values of housekeeping gene
Cyclophillin-A). A lower ∆Ct indicates stronger gene expression. Mann-Whitney U test
was applied to analyze the difference in ∆Ct between primary and SV40 immortalized
ISEMF. P-value <0.05 was considered significant. The data are representative of three
independent experiments. Error bar represents standard error of the mean (SEM).
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3.4 Discussion
ISEMF cells have diverse functions in wound healing, regulation of intestinal
epithelial barrier function, maturation and differentiation of intestinal epithelium,
orchestrating innate immune responses against invading pathogens, as well as role in the
progression of tumors, and inflammatory bowel disease (119, 121, 123, 128, 140-144).
Despite being cells with diverse functions, there is a paucity of knowledge about their
origin (128) and function in fibrosis, inflammation, and repair of the intestinal mucosa
(134, 145) primarily due to the absence of stable cell lines. Here, in this study, we
successfully established and characterized a primary and SV40 immortalized ileal ISEMF
cell lines from a 2-day old bovine male calf.
After isolation of intestinal sub-epithelial cells, they were cultured in fibroblast
supporting DMEM-10 media (134). These cells showed spindle to stellate morphology on
culture. On immunocytochemistry, these cells stained positively for cell specific markers
like α-SMA and vimentin but showed no staining for cytokeratin and weak staining for
desmin. There is a consensus understanding regarding the presence of α-SMA, vimentin
and absence of cytokeratin in intestinal myofibroblast cells (109, 110, 112, 127, 141).
The presence of myofibroblast specific markers along with polygonal morphology
confirmed the cells cultured in this study as ileal ISEMFs.
Intestinal myofibroblasts like other diploid cells undergo replicative senescence
due to shortening of telomerase (146) and thus can be cultured only for a finite number of
passages known as Hayflick’s limit (147). On reaching Hayflick’s limit they undergo
senescence and stop dividing. Previously established bovine colonic
myofibroblastsmaintainedtheir phenotype and proliferative capacity until passage 11
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(130). However, in this study we were able to maintain primary ileal cells up to 27
passages without losing proliferation and phenotypic characteristics. A possible
explanation for this variation may be that unlike ileal myofibroblasts, colonic
myofibroblasts need continuous stimulation with TGF-β to express myofibroblast marker
α-SMA (148). The difference in age of animal (2-day old calf vs adult), site of cell
isolation (ileum vs colon) and method of isolation could have resulted in this difference
although further experiments need to be carried out to support these arguments. In two
different studies, rat colonic myofibroblasts were successfully cultured up to 20 passages
by Kawasaki et al (134) and only up to 9 passages by Pourreyron et al (149). One
possible hypothesis for this discrepancy is that some cells can escape senescence
spontaneously and acquire high proliferative capacity (134, 149).
To immortalize primary ileal ISEMF cells, we transfected them with pSV3-neo
plasmid containing (Simian Virus) SV40 large T antigen gene. Large T antigen produces
tumor protein that binds with transformation related protein 53 (TRP53), Rb
(retinoblastoma ) proteins pRb, p107 and p130 resulting in suppression of cell cycle
arrest, and apoptosis (150). T antigen protein also binds to hsc70 causing the cell to enter
S-phase of the cell cycle (151, 152). In this study, we confirmed the presence of SV40
large T antigen gene in primary ileal ISEMFs by conventional PCR and confirmed the
synthesis of SV40 large T antigen protein in cells by indirect immunofluorescence assay.
SV40 immortalized ISEMFs retained myofibroblast morphology in culture and stained
positive for α-SMA, vimentin, and negative for cytokeratin. Immortalization of primary
cells by SV40 large T antigen has led to changes in expression of genes associated with
immune function, antigen presentation, and metabolism in other transformed cells (153).
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Therefore, we compared primary ISEMF cells and SV40 immortalized ISEMF in terms
of changes in glycobiology and pattern recognition receptors (PRRs).
We first compared primary and immortalized cells for the differences in their
lectin binding profile. Lectins are proteins that bind to carbohydrates, glycolipids or
glycoproteins in a reversible and non-catalytic manner (154, 155). Based on the type of
glycans lectins bind, lectins can be classified into various groups such as Nacetylglucosamine (GlcNAc), N-acetylgalactosamine (GalNAc), glucose, mannose,
galactose, fucose, sialic-acid specific lectins (156). In immune system two main lectin
groups are important; sialic-acid binding immunoglobulin like lectins (siglec) and C-type
(calcium dependent) lectins. Among many functions, siglecs are associated with
leukocyte adhesion and leukocyte homing. C-type lectins are involved in pathogen
recognition (157). C-type lectin receptors in cells have crucial functions in infection
regulation, autoimmunity, and cellular homeostasis (158). Pathogenic bacteria like
Burkholderia can use fucose-binding lectins in host recognition (159). Protozoan like
Entamoeba histolytica uses Gal-lectin for adherence to host cell glycans, Gal or GalNac
(160, 161). Similarly, mannose-binding lectins activate complement pathways, enhance
the immune response in concert with TLR 2/6, and bind to glycans on various pathogens
(162, 163). Low levels of serum mannose-binding lectins predispose to the risk of
Cryptosporidum infections in children (164). Lectins are also used as a cancer biomarkers
for certain cancers (165). Lectin binding is routinely used to study specific soluble and
cellular glycans and glycoconjugates expressed by specific cell types (166). Since all
eukaryotic cells have glycans in the form of glycolipids, and glycoproteins, there is
emerging evidence of their roles in cell signaling and cell adhesions.
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Out of 23 different lectins used in this study, RCA-120, LEL, GSL-I, STL, PHAE, and PHA-L showed higher cell percentage of stained cells (>80%) in both cell types.
Both primary and SV40 immortalized ileal ISEMF cells also stained fairly well for SNA,
MAL-II, SBA, Con-A, PNA, ECL, Jacalin; however, they showed no staining to very
faint staining for lectins UEA-I, SJA, VVA, GSL-II, DBA, PSA. SV40 immortalization
decreased the percentage of stained cells for lectins LEL, PHA-L, GSL-I, Jacalin, ECL,
Con-A, LCA, and PHA-L significantly. SV40 large T antigen mediated transformation of
primary cells into immortalized cells is widely used and accepted method but it’s
associated effects on cell physiology have not been widely studied (167). The
immortalized cells can have altered phenotypes than primary cells due to changes in
karyotype or due to loss of genes associated with phenotype (168, 169). There have been
few studies on changes in glycosylation before and after immortalization of cells and they
have shown altered glycosylation in transformed cell lines (170). There is increasing
evidence that surface glycans are linked with tumor progression primarily by altering the
glycosylation process (171-177). This could possibly be an explanation for variation in
altered glycans after immortalization. Studies on differences in surface glycan expression
by normal and tumor transformed cell line has shown a decrease in PHA-L binding in
tumor transformed cell line (178). Another possible reason could be the differences in
passage number. In this study, SV40 immortalized cells were of late passage, whereas
primary cells were of early passage. Studies on skin fibroblast cells have shown decrease
sialylation in aged individuals and in late passage fibroblast cells (179, 180). Further
study to identify a possible explanation for altered surface glycans in SV40 immortalized
ISEMFs is required to elucidate underlying mechanisms. The first step in the
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pathogenesis of various bacterial and viral disease is interaction and binding of glycanbinding protein (lectins) on specific surface receptors (surface glycans) on host cell (181184). Host cell uses these interactions to recognize pathogens and initiate an innate
immune response (185, 186). Thus, identification of pathogen lectins and host glycan
interactions could help in understanding disease pathogenesis (182). Expression of
surface glycans from the sialic acid group by ISEMF cells represents a target for viral
adhesions (187, 188). Various bacteria express adhesins. Some of the adhesins are
expressed in the form of mannose-specific type-I fimbriae, and N-acetylglucosamine
binding F-17 fimbriae (189). Expression of Mannose group glycans by ISEMF cells may
indicate a possible target of adhesion with various bacteria. Thus, these cells can be a
good model to study enteric bacterial and viral pathogenesis.
Historically, the role of stromal cells was thought to be limited to only a structural
function, but a plethora of evidence has emerged that shows vital role of these cells in
innate immune responses (190). ISEMF cells in mouse, rat, and human models have
shown their role in innate immunity (112, 125, 126, 191). To identify the expression of
toll-like receptors (TLRs) by primary ISEMF cells, RT-qPCR based mRNA expression
assay was used. Primary ISEMFs expressed TLRs 1-9 illustrating their role in innate
immunity in the intestine. To compare changes in TLR gene expression, if any, upon
immortalization with SV40 large T antigen, again RT-qPCR assay was used to compare
normalized Ct values (∆Ct ) for TLRs 1-9 of primary and SV40 immortalized ISEMFs.
Statistical analysis showed no significant differences in gene expression between the two
cell types.
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TLR is one of the groups in PRR family that recognizes pathogen associated
molecular patterns (PAMPs). These PAMPs are highly conserved across pathogens.
Recognition of PAMPs by TLRs results in production of pro-inflammatory and antiinflammatory cytokines by activation of MAPK/p38/JNK pathway, TAK1/NF-kB
activation, and IRF3 or IRF7 pathways (17, 23, 43, 192). Breach in epithelial layer by
invading pathogens may lead to activation of TLRs present in ISEMFs and consequently
initiation of signaling pathways resulting in the release of cytokines and chemokines.
Thus, ISEMFs are crucial in initiating an immune response against a pathogen that
reaches sub-epithelial layers (193). In this study both primary and SV40 immortalized
ISEMFs expressed various TLRs, another study needs to be carried out to evaluate the
responses of ISEMFs to PRR ligands.
3.5 Conclusion
We were able to isolate, establish and characterize a bovine primary ileal ISEMF
cell line. To delay replicative senescence, we immortalized this ISEMF cell line with
SV40 large T antigen mediated transformation. Comparison of primary and SV40
transformed ileal ISEMFs showed morphology and cell markers specific for subepithelial myofibroblast cells. Study of cell surface glycan showed a decrease in lectin
binding capacity for lectins GSL-I, PHA-L, LEL, Jacalin, ECL, Con-A, and LCA upon
immortalization of ISEMFs. This decrease in lectin binding could be the result of SV40
immortalization of primary ISEMFs or due to use of late passage cells for SV40
immortalized ISEMF. We also analyzed expression of TLRs in both primary and SV40
immortalized ISEMFs. Both cell type expressed TLR 1-9 and showed no significant
differences in TLR gene expression. So far to the author’s knowledge, this is the first
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instance of development of stable primary and immortalized bovine ileal ISEMF cell
lines from a young calf. These cell lines could be used to study a wide range of
physiological functions of ISEMFs and their role in disease pathogenesis. We intend to
use these cells in further studies to investigate their role in innate immunity and
pathogenesis of enteric diseases.
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Chapter 4. Role of bovine intestinal sub-epithelial myofibroblasts in innate immune
responses in the intestine

Abstract
Intestinal sub-epithelial myofibroblasts (ISEMFs) support the growth and
differentiation of intestinal epithelium. Further, their role as a generator of immune
responses in the sub-epithelial intestinal compartment is emerging. We have isolated,
developed and characterized a stable bovine ileal ISEMF cell line that expresses
myofibroblast markers including α-smooth muscle actin, and vimentin. Assessed by real
time-quantitative PCR (RT-qPCR) analysis, these cells expressed Toll like receptors
(TLRs) 1-9. In this study, we investigated their responses to various pattern recognition
receptors (PRRs) bacterial and viral ligands. Primary ileal ISEMF cells were stimulated
with PRR ligands for 3 hours or 24 hours. The RT-qPCR assay was employed to analyze
TLR and cytokine gene expression and quantified as fold expression changes. At 3 hours,
lipopolysaccharide (LPS) downregulated TLR 1, 4, 7, and 9 expression while
peptidoglycan (PGN) downregulated TLR 6 and 8. Similarly, flagellin (FLA)
downregulated TLR 4, 5, 7, 8, and 9 at 3 hours. At 24-hours LPS down regulated TLR 4
and FLA downregulated TLR 6. At 3 hours, bacterial ligand γ-D-Glu-mDAP (iE-DAP)
downregulated TLR 5 while muramyl dipeptide (MDP) and polyinosonic:polycytidylic
acid (Poly I:C) downregulated TLR 1. Poly I:C complexed with lyovec (Poly I:C/lyovec)
downregulated TLR 3 after 3-hours stimulation. We also analyzed cytokines expression
by RT-qPCR after stimulation with various bacterial and viral ligands. Interleukin 6 (IL6) was upregulated by LPS at 3 hours and 24 hours but downregulated by PGN at 24
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hours. At 24-hours IL-1α was upregulated by PGN and Poly I:C/lyovec. TNF-α was
downregulated by LPS at 24 hours while downregulated by FLA at 3 and 24 hours.
Imiquimod upregulated TNF- α upon 24-hour stimulation. Anti-inflammatory cytokine
IL-10 was downregulated by PGN upon 3-hour stimulation. As we observed changes in
TLRs, pro-inflammatory and anti-inflammatory cytokine genes expression, we infered
that bovine ISEMF cells responded to various bacterial and viral ligands. Thus, we
conclude that bovine ileal ISEMF cells play a pivotal role in host defense against
invading pathogens in the intestinal sub-epithelial compartment.

Key-words: intestinal sub-epithelial myofibroblasts, innate immunity, bovine, TLRs,
cytokines
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4.1 Introduction
Disruption of barrier function of intestinal epithelial cells exposes intestinal subepithelial compartment to numerous pathogens and leads to enteric inflammatory diseases
(194). The intestinal sub-epithelial compartment is populated with mesenchymal cells
and the interaction of surface epithelium and mesenchymal cells are crucial in the
maintenance of barrier function (195). Intestinal sub-epithelial myofibroblasts (ISEMFs)
are α-smooth muscle actin and vimentin positive mesenchymal cells (109-111) pivotal in
regulating barrier function, in fibrosis and healing, in differentiation, restitution, and
morphogenesis of epithelium (5, 6, 109, 110, 122, 124, 144). Mounting effective immune
response against invading pathogen in the intestinal sub-epithelial compartment is
essential and recent studies have shown that ISEMFs may be crucial in orchestrating
innate immune responses against invading pathogens (123, 128, 190).
Toll like receptors (TLRs), a type of pattern recognition receptors (PRRs), are
first to recognize and mount an effective innate immune response against invading
pathogens (23, 196). Binding of pathogen associated ligands to TLRs induces MyD88 or
TRIF dependent pathways leading to activation of NF-κB and MAPKs pathways and
release of cytokine or chemokines (25). In murine and human models ISEMFs have been
reported to express TLRs and respond to pathogen associated ligands by secreting
cytokines and chemokines (19, 112, 126, 134, 193, 197). Pro-inflammatory cytokines are
reported to be involved in cross-talk between intestinal epithelial cells and ISEMF cells
(195).
Cytokines like IL-33 from intestinal sub-epithelial myofibroblasts stimulates
intestinal stem cells and progenitor cells promoting differentiation of secretory intestinal
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epithelial cells (198). Thus, the study of the pattern of cytokine and chemokine
production from ISEMF cells in response to pathogen associated TLR ligands can open
new avenues to treat enteric diseases. Although ISEMFs express TLRs and NOD-like
receptors (NLRs) their elucidated response to various pathogen associated molecular
patterns (PAMPs) is still lacking (6, 126). ISEMF cells are suggested to enhance acquired
mucosal immune response as they have emerged as non-professional antigen presenting
cells (112, 125, 199). They are also reported to be involved in the induction of peripheral
tolerance in intestinal mucosa primarily through programmed death ligand-1 (PD-L1)
mediated suppression of CD4+ T cell activity (113, 114). Thus, further studies to
investigate the mechanism by which ISEMFs generate antagonistic responses is a must.
This suggests emerging role of ISEMFs as focal immune cells in intestinal mucosal
immunity.
We previously established and characterized stable bovine ISEMF cells that
express α-SMA and vimentin. On RT-qPCR assay ISEMF cells expressed TLRs 1-9. In
this study we investigated the response of ISEMF cells to various PRR ligands and
subsequent changes in the expression of pro- and anti- inflammatory cytokines and
chemokines.
4.2 Materials and Methods
4.2.1 Cell lines and culture conditions
Primary ISEMF cell line obtained from the ileum of the 2-day-old calf was used.
Cells were grown in Dulbeco’s Modified Eagle Medium (DMEM)-GlutaMax™
(GIBCO) supplemented with 10 % fetal calf serum (FCS: Atlanta Biologicals,
Lawrenceville, GA), pen-strep (100 IU/ml of penicillin and 100 ug/ml of streptomycin:
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Invitrogen), and 1% of non-essential amino acids (HyClone 100X; GE Health Care Life
Sciences). The supplemented media was named as myofibroblast media. In earlier study,
on phase contrast microscopy, ISEMFs showed spindle shape typical of myofibroblasts
morphology. Immunocytochemistry showed the presence of α-SMA and vimentin
confirming cells to be myofibroblasts. Moreover, the absence of cytokeratin indicated the
absence of contamination with epithelial cells. Cells were grown in T75 flasks (75 cm2,
Corning) in a humid chamber (370C, 5% CO2) until becoming confluent. Cells were
detached and harvested using 0.05% Trypsin-EDTA (Corning; Manassas, VA). Half
million cells were seeded into each well of six well tissue culture plate (Corning life
sciences) for stimulating with PRR ligands. After 48 hours of incubation in a humid
chamber, cells were washed three times with 1X phosphate buffered saline (PBS). Fresh
media was added along with PRR ligands at a specific concentration in duplicates. A
control was setup for each experiment. Each experiment was carried out in triplicates.
4.2.2 PRR ligands for stimulation of ISEMF cells
ISEMF cells were stimulated with PRR ligands for 3- and 24-hours using endtime alignment method. Lipopolysaccharide (LPS: catalog number L6529-1mg) from
Escherichia coli O55:B55 was used at 5 µg/ml concentration. Similarly, peptidoglycan
(PGN: catalog number tlrl-pgnsa) from Staphylococcus aureus was used at 10 µg/ml and
Flagellin (FLA: catalog number tlrl-stfla) from Salmonella typhimurium was used at 100
ng/ml. We also stimulated cells for 3-hours and 24-hours using ligands of cytosolic and
endosomal PRRs. γ-D-Glu-mDAP (iE-DAP: catalog number tlrl-dap) was used at10
µg/ml, muramyl dipeptide (MDP: catalog number tlrl-mdp) at 10 µg/ml,
polyinosonic:polycytidylic acid (Poly I:C: catalog number tlrl-pic) at 5 µg/ml, Poly I:C
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complexed with lyovec (Poly I:C/lyovec: catalog number tlrl-piclv) at1 µg/ml, and
imiquimod ( catalog number tlrl-imq) at 5 µg/ml. All the ligands were bought from
Invivogen, CA, USA. For stimulating cells with bacterial ligands, primary ISEMF cells
from passage 15-20 were used. For stimulating cells with cytosolic and endosomal PRR
ligands, cells from passage 18-24 were used.
4.2.3 RNA extraction and cDNA preparation
After 3 hours or 24 hours of incubation with ligands, cells were washed three
times with 1X PBS. Cells were then trypsinized using 0.05% Trypsin-EDTA and
centrifuged to form a pellet. RNA was extracted from pelleted cells using RNeasy Mini
Kit (catalog number 74101, Qiagen, Valencia, CA, USA) and kit protocol. RNA was
quantified using Thermo Scientific™ NanoDrop 2000. The RNA thus obtained was used
to prepare cDNA. 1 µg of RNA was reverse transcribed to cDNA using TaqMan reverse
transcription kit and kit protocol (TaqMan reverse transcription reagents, Applied
Biosystems, catalogue number N8080234).
4.2.4 Real time-quantitative PCR (RT-qPCR) for quantifying gene expression
For RT-qPCR 2 µl of diluted cDNA (1:5 dilutions), 1 µl each of forward and
reverse primers, 10 µl of RT² SYBR® Green/ROX qPCR mastermix (catalog number
330501, Qiagen, Valencia, CA, USA) and 6 µl of nuclease free water was added to bring
total reaction volume to 20 µl. The thermal profile used for amplification was: 2 minutes
at 500C; 10 minutes at 950C; followed by 40 cycles of 45 seconds (15 seconds for
cytokine genes) at 950C, 30 seconds at 600C and 30 seconds at 720C. Ramping speed was
set at 1.60C/second. QuantStudio™ 6 Flex Real-Time PCR System (Applied Biosystems,
NJ, USA) was used. Data were normalized using the housekeeping gene (Cyclophillin-
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A). Primer sequence previously used (138) for amplification of TLR 1-9 gene and
Cyclophillin-A as housekeeping gene (139) are listed in Table 5. RT-qPCR was also used
to identify any changes in pro-inflammatory and anti-inflammatory cytokines, after
stimulation with PRR ligands. List of cytokine and chemokine primers (138, 200) is
provided in Table 6.

Table 5: Primer sequence of genes along with gene bank accession number used in
analysis of TLRs expression of ISEMF cells
Forward primer

Reverse primer

Accession
number

TLR 1

TLR 2

TLR 3

TLR 4

TLR 5

TLR 6

TLR 7

TLR 8

CAT TCC TAG CAG CTA

TGG GCC ATT CCA AAT

NM_001046

CCA CAA GCT

AAG TTC T

504

GGG TGC TGT GTC ACC

GCC ACG CCC ACA TCA

NM_174197

GTT TC

TCT

GGG CAC CTG GAG GTC TTC CTG GCC TGT GAG

NM_001008

CTT

TTC TTG

664

AGC ACC TAT GAT GCC

GTT CAT TCC GCA CCC

NM_174198

TTT GTC A

AGT CT

GTC CCC AAC ACC ACC

GCG GTT GTG ACT GTC

NM_001040

AAG AG

CTG ATA TAG

501

TTT ACC CTC AAC CAC

GGG CCA AAG GAA CTG

NM_001001

GTG GAA

AAA AAC

159

CAC CAA CCT TAC CCT

GTC CAG CCG GTG AAA

NM_001033

CAC CAT T

GGA

761

TGT GTT TAG AGG AAA

TCT GCA TGA GGT TGT

NM_001033

GGG ATT GG

CGA TGA

937
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TLR 9

CAG TGG CCA GGG

CCG GTT ATA GAA GTG

TAG TTT CTG

ACG GTT GT

Cyclophilin-A CTTTCACAGAATAATTC CAGTACCATTATGGCGTG
CGGGATT

NM_183081

BC105173

TGAAG

Table 6: Primer sequence of genes along with gene bank accession number used in
analysis of cytokine expression of ISEMF cells
Forward primer

Reverse primer

Accession
number

IL-1α

IL-1β

CAG TTG CCC ATC CAA

TGC CAT GTG CAC CAA

NM_174092

AGT TGT T

TTT TT

GAG CCT GTC ATC TTC

GCA CGG GTG CGT CAC A

NM_174093

CGC ATT GCA GTC TCC

GGG CTC TTG ATG GCA

NM_173966

TAC CA

GAC A

GAA ACG
TNF-α

IL-6

IL-8

IL-10

CCA CCC CAG GCA GAC CCA TGC GCT TAA TGA
TAC TTC

GAG CTT

TGC TCT CTT GGC AGC

TCT TGA CAG AAC TGC

TTT CC

AGC TTC AC

AAGGTGAAGAGAGTCT

TGCATCTTCGTTGTCATGT

TCAGTGAGC

AGG

NM_173923

NM_173925

NM_174088

4.2.5 Statistical analysis for interpretation of RT-qPCR data
To compare the changes in TLR expression after ligand stimulation, double delta
Ct (ΔΔCt) was calculated using the method previously described (201). Change in
mRNA gene expression was calculated as 2-ΔΔCt. The method uses the following
equation to calculate ΔΔCt:
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ΔΔCt=∆Ct Treatment (Ct of reference gene Treatment-Ct Housekeeping gene
Treatment)- ∆Ct Control (Ct of reference gene Control-Ct Housekeeping gene Control).
A two tailed Student’s t-test was then used to compare fold expression changes
after treatment with ligands. A p-value of less than 0.05 (p<0.05) was considered
significant. GraphPad prism 7.04 was used to prepare graphs. Data are expressed as a
mean ± standard error of the mean.
4.3 Results
4.3.1 Innate responses of ISEMF cells after 3-hours and 24-hours stimulation with
bacterial ligands of surface PRRs
LPS significantly downregulated TLR 1 (0.69±0.05, p=0.02), TLR 4 (0.52±0.08,
p=0.03), TLR 7 (0.56±0.04, p=0.01), and TLR 9 (0.7±0.05, p=0.03) (Figure 13);
however, PGN significantly downregulated TLR 6 (0.78±0.04, p=0.03), and TLR 8
(0.64±0.08, p=0.04) (Figure 14) gene expression at 3-hour time point. FLA
downregulated TLR 4 (0.6±0.08, p=0.04), TLR 5 (0.51±0.06, p=0.01), TLR 7
(0.68±0.04, p=0.02), TLR 8 (0.55±0.06, p=0.02), and TLR 9 (0.6±0.01, p=0) (Figure 15)
gene expression at 3-hour time point. Upon analysis of cytokine genes expressions, we
found that LPS significantly upregulated IL-6 (7.63±0.89, p=0.02) (Figure 16), PGN
downregulated TNF-α (0.56±0.05, p=0.01) and IL-10 (0.23±0.11, p=0.02) (Figure 17)
while FLA only downregulated TNF-α (0.47±0.07, p=0.02) (Figure 18) gene expression
at 3-hour time point.
After 24-hour stimulation, LPS downregulated TLR 4 (0.75±0.06, p=0.04)
(Figure 13) and FLA downregulated TLR 6 (0.77±0.02, p=0.01) (Figure 15) genes
expressions while PGN had no significant differences in TLR expression (Figure 14).
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Upon analysis of cytokine genes expressions at 24-hour time point, we found that LPS
significantly upregulated IL-6 (3.6±0.28, p=0.01) and downregulated TNF-α (0.53±0.05,
p=0.01) (Figure 16) genes. After 24-hour stimulation, PGN significantly upregulated IL1α (1.32±0.05, p=0.02) and downregulated IL-6 (0.94±0.01, p=0.02) (Figure 17) while
FLA downregulated TNF-α (0.53±0.09, p=0.04) (Figure 18) genes expressions.
Interestingly, no significant changes in the IL-8 gene expression were observed in
response to LPS, PGN, and FLAs stimulation for 3 and 24 hours.
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Fig 13: Fold changes in TLRs genes expressions in ISEMF cells upon stimulation with
LPS. Data are expressed as a mean of 3 independent experiments and error bar represents
standard error of the mean. A significant difference in gene expression after LPS
treatment is denoted by an asterisk (*=p<0.05, **=p≤0.01).
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Fig 14: Fold changes in TLRs genes expressions in ISEMF cells upon stimulation with
PGN. Data are expressed as a mean of 3 independent experiments and error bar
represents standard error of the mean. A significant difference in gene expression after
PGN treatment is denoted by an asterisk (*=p<0.05, **=p≤0.01).
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Fig 15: Fold changes in TLRs genes expressions in ISEMF cells upon stimulation with
FLA. Data are expressed as a mean of 3 independent experiments and error bar represents
standard error of the mean. A significant difference in gene expression after FLA
treatment is denoted by an asterisk (*=p<0.05, **=p≤0.01).

75

LPS (24 hour)

95
75
55
35
15
15
10

*

5

IL-10

IL-8

IL-6

TNF-alpha

IL-1 beta

**
IL-1 alpha

0

**
Control

Fold changes in mRNA

LPS (3 hour)

Cytokines

Fig 16: Fold changes in cytokines genes expressions in ISEMF cells upon stimulation
with LPS. Data are expressed as a mean of 3 independent experiments and error bar
represents standard error of the mean. A significant difference in gene expression after
LPS treatment is denoted by an asterisk (*=p<0.05, **=p≤0.01).
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Fig 17: Fold changes in cytokines genes expressions in ISEMF cells upon stimulation
with PGN. Data are expressed as a mean of 3 independent experiments and error bar
represents standard error of the mean. A significant difference in gene expression after
PGN treatment is denoted by an asterisk (*=p<0.05, **=p≤0.01).
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Fig 18: Fold changes in cytokines genes expressions in ISEMF cells on stimulation with
FLA. Data are expressed as a mean of 3 independent experiments and error bar represents
standard error of the mean. A significant difference in gene expression after FLA
treatment is denoted by an asterisk (*=p<0.05, **=p≤0.01).
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4.3.2 Innate responses of ISEMF cells after 3-hour and 24-hour stimulation with
ligands of cytoplasmic and endosomal PRRs
After 3-hour stimulation, iE-DAP, a ligand for NOD-1 significantly
downregulated TLR 5 (0.76±0.04, p=0.02) (Figure 19), MDP, a ligand for NOD-2
downregulated TLR 1 (0.73±0.04, p=0.02) (Figure 20), Poly I:C, a ligand for TLR 3
downregulated TLR 1 (0.74±0.03, p=0.01) (Figure 21), and Poly I:C/lyovec, a ligand for
RIG-I and MDA-5 downregulated TLR 3 (0.49±0.05, p=0.01) gene expression.
Imiquimod, a ligand for TLR 7 and 8 did not alter expression of any of the 9 TLRs
(Figure 23). None of the ligands for cytosolic and endosomal PRRs, after 3-hour
stimulation, significantly altered the expression of cytokines investigated in this study
(Figure 24-28). We could not detect expression of cytokine IL-10 after 3-hour stimulation
with ligand MDP indicating downregulation of IL-10 gene expression (Figure 25).
Upon 24-hour stimulation, we observed no significant changes in TLR expression
in response to any ligands of both cytosolic and endosomal PRRs (Figure 19-23).
However, Poly I:C/lyovec significantly upregulated cytokine IL-1α (2.4±0.25, p=0.03)
(Figure 27) and imiquimod significantly upregulated TNF-α cytokine gene expression
(1.83±0.15, p=0.03) (Figure 28) after 24 hours of ligand stimulation. The expression of
IL-10 gene remained undetected after both 3 hour and 24 hour stimulation indicating
downregulation of IL-10 gene expression.
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Fig 19: Fold changes in TLRs genes expressions in ISEMF cells upon stimulation with
iE-DAP. Data are expressed as a mean of 3 independent experiments and error bar
represents standard error of the mean. A significant difference in gene expression after
iE-DAP treatment is denoted by an asterisk (*=p<0.05, **=p≤0.01).
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Fig 20: Fold changes in TLRs genes expressions in ISEMF cells upon stimulation with
MDP. Data are expressed as a mean of 3 independent experiments and error bar
represents standard error of the mean. A significant difference in gene expression after
MDP treatment is denoted by an asterisk (*=p<0.05, **=p≤0.01).
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Fig 21: Fold changes in TLRs genes expressions in ISEMF cells upon stimulation with
Poly (I:C). Data are expressed as a mean of 3 independent experiments and error bar
represents standard error of the mean. A significant difference in gene expression after
Poly (I:C) treatment is denoted by an asterisk (*=p<0.05, **=p≤0.01).
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Fig 22: Fold changes in TLRs genes expressions in ISEMF cells upon stimulation with
Poly (I:C)/Lyovec. Data are expressed as a mean of 3 independent experiments and error
bar represents standard error of the mean. A significant difference in gene expression
after Poly (I:C)/Lyovec treatment is denoted by an asterisk (*=p<0.05, **=p≤0.01).
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Fig 23: Fold changes in TLRs genes expressions in ISEMF cells upon stimulation with
imiquimod. Data are expressed as a mean of 3 independent experiments and error bar
represents standard error of the mean. A significant difference in gene expression after
imiquimod treatment is denoted by an asterisk (*=p<0.05, **=p≤0.01).
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Fig 24: Fold changes in cytokines genes expressions in ISEMF cells upon stimulation
with iE-DAP. Data are expressed as a mean of 3 independent experiments and error bar
represents standard error of the mean. A significant difference in gene expression after
iE-DAP treatment is denoted by an asterisk (*=p<0.05, **=p≤0.01).
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Fig 25: Fold changes in cytokines genes expressions in ISEMF cells upon stimulation
with MDP. Data are expressed as a mean of 3 independent experiments and error bar
represents standard error of the mean. A significant difference in gene expression after
MDP treatment is denoted by an asterisk (*=p<0.05, **=p≤0.01).
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Fig 26: Fold changes in cytokines genes expressions in ISEMF cells upon stimulation
with Poly (I:C). Data are expressed as a mean of 3 independent experiments and error bar
represents standard error of the mean. A significant difference in gene expression after
Poly (I:C) treatment is denoted by an asterisk (*=p<0.05, **=p≤0.01).
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Fig 27: Fold change in cytokines genes expressions in ISEMF cells upon stimulation with
Poly (I:C)/Lyovec. Data are expressed as a mean of 3 independent experiments and error
bar represents standard error of the mean. A significant difference in gene expression
after Poly (I:C)/Lyovec treatment is denoted by an asterisk (*=p<0.05, **=p≤0.01).
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Fig 28: Fold changes in cytokines genes expressions in ISEMF cells upon stimulation
with imiquimod. Data are expressed as a mean of 3 independent experiments and error
bar represents standard error of the mean. A significant difference in gene expression
after imiquimod treatment is denoted by an asterisk (*=p<0.05, **=p≤0.01).
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4.4 Discussion
In this study bovine ileal ISEMF cells expressed various TLRs and responded to
various bacterial and viral ligands of PRRs by changing the expression of various proinflammatory and anti-inflammatory cytokines (126). Inflammatory diseases of intestine
or disruption of intestinal epithelium make sub-luminal compartment accessible to
luminal antigens and pathogens to which ISEMFs respond by producing cytokines,
chemokines, extracellular matrix components that modulate immune cells recruitment
and activation (123, 202, 203). Cytokines and chemokines released in intestinal lumen or
in the sub-epithelial compartment are key players in regulating barrier integrity (195,
204). Understanding cell specific response and intracellular mechanism that generates
innate immune responses against enteric pathogens are crucial for the development of
prophylaxis against such pathogens (126).
We first analyzed putative TLRs 1-9 expression in bovine ileal ISEMF cells. To
identify if these cells respond to various pathogen associated molecular patterns and
initiate any downstream signaling, we stimulated cells for either 3 hours or 24 hours with
various ligands of PRRs. Stimulation for 3 hours mimicked early innate immune response
while 24 hours mimicked late innate immune response. LPS significantly downregulated
TLR 1, 4, 7, and 9 genes expressions after 3-hour stimulation and downregulated TLR 4
after 24-hour stimulation. LPS upregulated IL-6 gene expression at both 3 hours and 24
hours and downregulated TNF-α after 24-hour. The expression of TLR 4 to which LPS
binds was downregulated by LPS stimulation (0.52 folds at 3 hours and 0.75 folds at 24
hours) and coincided with decreasing trend of IL-6 expression (7.63 fold at 3 hours and
3.6-fold at 24 hours) at 3 to 24 hours. LPS from gram negative bacteria is a potent
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immunostimulatory structure. LPS consists of endotoxin Lipid A, core oligosaccharide,
and O-antigen. Lipid A is recognized by TLR 4 (205, 206). LPS recognition by TLR 4
requires accessory molecules. LPS binding protein binds to LPS allowing the association
between LPS and co-receptor CD14 (monocyte differentiating antigen). CD-14 facilitates
the binding of LPS to TLR 4/MD-2 complex (207, 208). Recognition of LPS by TLR 4
leads to signal transduction either by MyD88 (209) or TRIF pathway (210) ultimately
leading to activation of transcription factors like NF-κB, AP-1, and IRF-3. Activation of
transcription factors results in expression of pro-inflammatory cytokines like IL-6, IL-8,
TNF-α, and type -I IFN (20, 211). Previous studies have shown that LPS stimulates
expression of IL-6 in hepatic myofibroblasts (212). Murine intestinal myofibroblasts also
expressed TLR 4 and demonstrated elevated levels of IL-6 when measured at 8-hour post
stimulation with LPS (126). Continued activation of TLR 4 can lead inflammation
induced damages and thus negative regulation needs to be in place. Radioprotective
protein 105 (RP105), single immunoglobulin IL-1R-related molecule, IL1-RL1 protein
negatively regulate TLR 4 signaling. LPS challenged mice that are deficient for RP105
showed elevated levels of TNF-α in serum (213). Thus, downregulation of TNF- α after
24-hour stimulation with LPS in this study could probably be the result of negative
signaling. After TLR signaling, the LPS-TLR4-MD2 complex is endocytosed in
endosome or lysosomes where degradation of TLR 4 occurs (214). This degradation can
result in the termination of TLR 4 induced production of TNF (215). In human colonic
myofibroblasts LPS altered the expression of TLR 2, 3, 4, 6, 7 indicating that LPS could
alter expression of other TLRs apart from its specific receptor TLR 4 (193) also observed
in this present study.

91
Peptidoglycan (PGN) is a major constituent of gram positive bacteria cell wall
and is composed of N-acetlyglucosamine (GlcNac) and N-acetylmuramic acid (MurNac)
linked by β-(1-4) linkage (49). PGN’s role in inducing an inflammatory response and in
stimulating innate immune responses has been long known (50, 51). TLR 2 knocked out
mice revealed that TLR 2 is involved in recognition of PGN (216). In various cell
models, PGN induced production of pro-inflammatory cytokines like IL-6, IL-1α/β, TNFα (217). In this study, TLR 6 and TLR 8 were significantly downregulated at 3 hours
along with downregulation of TNF-α and IL-10. IL-1α was upregulated while IL-6 was
marginally downregulated after 24 hours with PGN stimulation. Unlike LPS stimulation,
PGN stimulation did not alter TLR 2 expression at 3-hour or 24-hour time point. In
earlier studies stimulation of rat intestinal myofibroblast cultures with cell wall polymers
altered expression of cytokines like IL-1β and IL-6 (218) and mice corneal fibroblast
cultures also responded to PGN treatment by altering expression of TLRs other than TLR
2 (219).
TLR 1 and TLR 6 are functionally co-related with TLR 2 in recognizing different
classes of lipopeptides (220). Most of the studies co-relating PGN to TLR 2 used
commercially obtained PGN from Staphylococcus aureus. This preparation is often copurified with other cell wall components and pure PGN has failed to respond to TLR 2 in
many experiments (221). The authors (221) even claimed that PGN sensing did not occur
via TLR 2 which was later refuted (222).
Flagellin (FLA), a subunit of flagellum protein provides motility to the bacterium.
Flagellin initially was considered as a virulence factor but subsequent in-vitro studies
demonstrated its pro-inflammatory role (223, 224). Later it was demonstrated that
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recognition of flagellin by TLR 5 induced production of pro-inflammatory cytokines like
TNF-α, IL-1β (225). In this study, 3- and 24-hours stimulation with flagellin
downregulated TNF-α gene expression at both time points. TLR 4, 5, 7, 8, 9 genes
expressions were downregulated at 3 hours while TLR 6 gene expression was
downregulated at 24 hours. With three of these bacterial PRR ligands (LPS, PGN, and
FLA) used in this study, we observed an alteration in expression of both cognate and noncognate receptors. Recent studies have shown cross talk among these PRRs and that PRR
ligand can overexpress or inhibit expression of other PRRs. Among multiple ligands, LPS
showed a more pronounced effect on modulating expression of other PRRs, and PAMPs
other than LPS downregulated the expression of TLR 4 (226). Triggering of single TLR
when the specific ligand is recognized is insufficient to mount an effective innate
immune response and thus triggering of other PRR family or multiple TLR may be
required to mount a strong immune response. Often the synergism is between PRRs that
mediate effector response through different signaling pathways (43, 227).
Nucleotide-binding oligomerization domain (NOD) proteins are cytoplasmic
proteins involved in recognition of intracellular bacteria or their cell wall products. NOD
proteins have N-terminal caspase recruitment domain (CARD), leucine rich repeats in Cterminus and nucleotide binding domain in between. NOD-1 and NOD-2 are two NOD
proteins that recognize two different peptidoglycan fragments and are involved in
pathogen recognition (48). NOD-1/CARD4 recognizes peptidoglycan GlcNAc-MurNAcL-Ala-γ-D-Glu-meso-DAP (GM-TriDAP/iE-DAP) whereas NOD-2 recognizes muramyl
dipeptide, MurNAc-L-AlaD-isoGln. NOD-1 and NOD-2 activate NF-κB by recruitment
of receptor-interacting protein (RIP) 2 leading to secretion of pro-inflammatory cytokines
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while type I interferons are secreted when IRF3/IRF7 dependent pathway is activated by
these receptors (52-56). In this study, iE-DAP significantly downregulated TLR 5 while
MDP downregulated TLR 1 gene expression after 3-hour stimulation with no changes in
cytokine expression. MDP alone has been shown to evoke weak immune stimulation (47,
228-231). However, addition of TLR agonists like LPS, lipoteichoic acid along with
MDP has been shown to evoke a strong immune response (232, 233). TLR stimulation
may promote internalization of MDP and iE-DAP which facilitates recognition by NOD
proteins. NOD proteins also interact with other intracellular molecules such as GRIM-19,
RIG-1, vimentin, RIPK2, NLRP1, that positively or negatively regulate NOD signaling
pathways (47).
During viral replication, most of the viruses produce double stranded RNA
(dsRNA) as replication intermediate. This dsRNA is sensed by PRRs present in the cell
membrane, cytosol, and endosomes. TLR 3 is membrane receptor usually present in
endosomes and recognizes dsRNA. Retinoic acid-inducible gene I (RIG-I), melanoma
differentiation-associated gene -5 (MDA-5), and NLR pyrin domain 3 (Nlrp3) are present
in the cytosol and associated with sensing of dsRNA (62, 234-237). Recognition of
dsRNA by these receptors results in the production of type -I interferon (IFN) (238, 239).
TLR 3 uses MyD88 independent pathway and uses toll/interleukin-1 receptor (TIR)
domain-containing adaptor inducing IFN-β (TRIF) ultimately leading to induction of
IFN-β (210, 240, 241). Poly (I:C) is the synthetic analog of dsRNA and is used to mimic
viral infection in experimental conditions (242, 243). Recent reports have shown possible
role of CD14 in internalizing extracellular dsRNA or poly (I:C) and delivering to TLR 3
located in the endosomal and lysosomal membrane (244). Apart from IFN, IL-6 induced
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from TLR 3 expression is reported to have a detrimental effect during infection with
single stranded RNA viruses (245-247). Apart from IFN production, NF-κB activation
also induces secretion of IL-32. IL-32 induces production of pro-inflammatory cytokines
like IL-6, IL-8, TNF-α, IL-1β (241, 248). With ISEMF cells in this study, we observed
downregulation of TLR 1 gene expression at 3-hour stimulation with poly (I:C) however;
we did not observe any significant changes in cytokines and TLR 3 expression.
Poly (I:C) complexed with lyovec is Poly (I:C) complexed with a transfecting
reagent that allows Poly (I:C) to be released into the cytoplasm. Accumulation of
intracellular dsRNA during viral replication and subsequent induction of IFN production
by the host cell is different from the IFN produced by sensing of extracellular dsRNA
(249). Intracellular dsRNA is sensed by RIG-I, and MDA-5. Proteins RIG-I and MDA-5
belong to RIG-I like receptor (RLR) family. RIG-I senses blunt ended 5’phosphorylated
dsRNA whereas MDA-5 recognizes long (>1000 nucleotide) dsRNA (58-60). Both RIG-I
and MDA-5 are RNA helicases that have caspase recruitment domain (CARD) and
helicase domain. Signal transduction after sensing of intracellular dsRNA is through
CARD in both RIG-I and MDA-5. This results in activation of IRF-3 and NF-κB and
subsequent production of IFNs (type I, and type III) and as well as pro-inflammatory
cytokines like IL-6 and IL-8 (61-64). However, poly (I:C) complexed with transfecting
reagent lyovec in this study downregulated TLR 3 gene expression and significantly
upregulated IL-1α gene expression.
Imiquimod is a synthetic guanosine analog with antiviral and anti-tumor activity
(250). Imiquimod is an immune response modifier that specifically activates TLR 7
signaling pathway (251). Through MyD88 signaling cascade imiquimod induces
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activation of transcription factors like NF-κB and MAPKs (mitogen activated protein
kinases). Activation of these transcription factors leads to induction of IFN-α, IL-12,
TNF-α, IL-6 and other cytokines (250, 252-255). In this study, ileal ISEMF cells
responded to imiquimod by upregulation of TNF-α gene expression after 24-hours
stimulation but no changes in expression of TLR genes were observed. Immune cells like
phagocytes produce reactive oxygen species (ROS) during the microbial invasion. These
ROS are highly reactive and induce oxidative damage to nucleic acids, lipids, and
proteins. Guanosine and cytosine are more prone to undergo oxidative damage due to
their electronic configuration. Such damaged guanosine may be sensed by TLR 7 and
TLR 8 and produce necessary cytokines for activating immune cells (251, 256).
With most of the bacterial and viral ligands used in this study, we observed
downregulation of TLRs. Some studies have suggested that TLR upregulation may favor
entry of pathogens, especially in intestinal epithelium. In intestinal epithelium, TLRs
upregulations is found to be associated with disruption of barrier function and thus may
favor entry of pathogens (257). Thus, based on the findings of this study, intestinal
myofibroblasts may also be involved in antiviral response and in activation of immune
cells.
4.5 Conclusion
In this study, we investigated the putative expression of TLRs by bovine ileal
ISEMF cells asthere has been a limited number of studies on the expression of PRRs by
intestinal myofibroblast cells. To the author's knowledge, no studies on the role of bovine
intestinal sub-epithelial myofibroblasts in innate immunity have been carried out so far.
This study also analyzed the responses of bovine ISEMFs to various PAMPs and
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associated cytokines expression. This study did not analyze expression of NLRs and
RLRs in ileal ISEMFs. This study only analyzed changes in gene expression in response
to various PAMPs. This study is limited in scope as it did not analyze whether alterations
in mRNA expressions were being carried out to protein level. No experiment to quantify
cytokine level in cell culture supernatant was performed and changes in IFN gene in
response to viral PAMPs was not analyzed. Despite these limitations, we demonstrated
that bovine ileal ISEMF express TLRs 1-9 and respond to various bacterial and viral
PAMPs. Based on our experiments we can conclude that bovine ISEMFs are involved in
generating an innate immune response in the intestinal sub-epithelial compartment. Thus,
this cell line can be used to accumulate knowledge of signal transduction in response to
various bacterial and viral PAMPs. This bovine ISEMF cell line can be an excellent invitro model to study innate immune responses occurring at intestinal mesenchyma.
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Chapter 5. Role of bovine ileal epithelial cells in innate immune responses in the
intestine

Abstract
Intestinal epithelium plays important role not only in digestion but also in the
maintenance of homeostasis in gastro-intestinal (GI) tract. It serves as a physical barrier
in separating gut microbiota and lumen. There is a dynamic interaction among intestinal
epithelial cells, intestinal mucosa and gut microbes. Knowledge of this interaction is
essential for the better understanding of inflammatory and infectious enteric diseases
where this delicate interaction is perturbed. Intestinal epithelial cells being equipped with
pattern recognition receptors (PRRs) along with their proximity to gut microbiota play
significant role in mounting innate immune responses to gut antigens and pathogens as
well as in the maintenance of peripheral tolerance. We used cloned bovine-intestinal
epithelial cell line (BIEC-c4) earlier developed from the ileum of the 2-day old calf to
study putative expression of Toll like receptors (TLRs) and their responses to bacterial
and viral pathogen associated molecular patterns (PAMPs). BIEC-c4 cells were
stimulated with various PRR bacterial and viral ligands for 3 and 24 hours. The RTqPCR assay was employed to analyze TLRs and cytokines gene expression and
quantified as fold expression changes. At 3 hours, we observed no changes in TLR
expression after stimulation of BIEC-c4 cells with the lipopolysaccharide (LPS),
peptidoglycan (PGN), and flagellin (FLA). At 24-hour peptidoglycan PGN upregulated
expression of TLR 3 and 9. LPS upregulated interleukin 8 (IL-8) and IL-10 at 3 hours
while IL-6 and IL-8 were upregulated at 24 hours. FLA downregulated IL-1β gene
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expression at 3-hour after stimulation. Ligand γ-D-Glu-mDAP (iE-DAP) and muramyl
dipeptide (MDP) upregulated TLR 9 expression at 3 and 24 hours after stimulation
respectively. However polyinosonic:polycytidylic acid (Poly I:C) upregulated both TLR
8 and TLR 9 expression after 3 hours of stimulation. Poly I:C complexed with lyovec
(Poly I:C/lyovec) and imiquimod did not alter expression of any TLRs. Overall, findings
of this study suggest that theBIEC-c4 cells serve as a good in-vitro model to study
immune responses specifically against bacterial pathogens.

Keywords: bovine intestinal epithelial cells, TLRs, cytokines, innate immunity
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5.1 Introduction
Intestinal epithelium is important in digestion and nutrients uptake. It is also
involved in the maintenance of homeostasis in gastro-intestinal (GI) tract. It serves as a
physical barrier in separating gut microbiota and luminal content from intestinal submucosa. The intestine is equipped with the largest arsenal of immune cells (204).
Intestinal epithelial cells (IECs) play a significant role in inducing innate immune
responses against invading pathogens. With both commensals and pathogens residing in
the intestine, intestinal epithelial cells need to selectively mount an immune response
against pathogens and develop tolerance against commensals. This dual task of
maintaining tolerance as well as generating immune response surmounts unique
challenge to the mucosal surface and specifically to intestinal epithelial cells (258).
IECs secrete antimicrobial peptides like defensins and calprotectins that have
broad-spectrum anti-bacterial activity (259-261). IECs express pattern recognition
receptors (PRRs) that sense various pathogen associated molecular patterns (PAMPs).
IECs being equipped with PRRs along with their proximity to gut microbiota have been
shown to play role in mounting an innate immune response as well as in the maintenance
of peripheral tolerance (262-264). Toll like receptors (TLRs), a type of pattern
recognition receptors (PRRs), are first to recognize and mount an effective innate
immune response against invading pathogens (23, 196). Ten TLRs (TLR 1-10) have been
reported in a bovine system with bovine intestinal epithelial cells expressing all ten of
them (265-267). TLRs 1, 2, 4, 5, 6, 10 are expressed on the cell surface whereas TLR 3,
7, 8, 9 are intracellular and located in endosomes. Cell surface TLRs sense protein, lipid
and lipopolysaccharide PAMPs while intracellular TLRs sense nucleotide PAMPs (7, 25,
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268). Binding of pathogen associated ligands to TLRs induces MyD88 or TRIF
dependent pathways leading to activation of NF-κB and MAPKs pathways and release of
cytokines or chemokines (25). Cytokines like IL-17, IL-10, IL-22, IL-36, IL-6 upregulate
JAK-STAT pathway leading to increased expression of target genes essential for
epithelial regeneration, proliferation, barrier integrity, activation of the adaptive immune
system and pathogen clearance. (269-273).
Development of stable intestinal epithelial cells that express PRRs and respond to
PAMPs is pivotal in establishing an in-vitro model for studying enteric disease
pathogenesis, signaling pathways and innate immune responses to pathogens. Cattles
harbor enteric pathogens like enterotoxigenic Escherichia coli, Salmonella,
Campylobacter, Mycobacterium, Listeria, Leptospira that cause huge economic losses to
the livestock industry. Many of such zoonotic pathogens are equally important from a
public health perspective (274-276). Development of host specific cell line helps in better
understanding of disease pathogenesis and immune responses. There are limited number
of stable primary cell lines available from the bovine intestine (265). Most of the
intestinal cell lines are either from adult cattle or from fetal tissues. Unavailability of
intestinal epithelial cell lines from young calves have hindered studies on enteric
pathogens like bovine rotavirus, bovine coronavirus, and bovine viral diarrhea virus that
infect young calves (135, 277).
Analysis of PRRs in the intestine, preferential activation of PRRs by pathogens,
and cytokine signaling associated with PRR activation is essential for better
understanding of gut immunity (264). In this study, we used an established and
characterized cloned primary bovine intestinal cell line (BIEC-c4) from the ileum of the
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2-day old calf which expressed TLR 1-9 as assessed by RT-qPCR assay. Here, we
investigated the innate immune responses of BIEC-c4 cell line to various bacterial and
viral PAMPs.
5.2 Materials and Methods
5.2.1 Cell lines and culture conditions
Cloned primary bovine intestinal epithelial cells (BIEC-c4) obtained from the
ileum of the 2-day-old calf were used in this study. BIEC-c4 cells were grown in
DMEM/F12 (Dulbeco’s Modified Eagle Medium; GIBCO) media supplemented with 5%
fetal calf serum (FCS: Atlanta Biologicals, Lawrenceville, GA), pen-strep (100 IU/ml of
penicillin, 100 ug/ml of streptomycin: Invitrogen), 0.1% of mouse epidermal growth
factor (EGF; Corning®, catalog number 4069007), and 0.1 % each of insulin, human
transferrin and selenous acid (ITS; Corning®, catalog number 354351). The
supplemented media was named as epithelial cell media. Cells were grown in T75 flasks
(75 cm2, Corning) in a humid chamber (370C, 5% CO2) until becoming confluent. Cells
were detached and harvested using 0.05% Trypsin-EDTA (Corning; Manassas, VA). Half
million BIEC-c4 cells were seeded in each well of a six well tissue culture plate (Corning
life sciences) for stimulating these cells with PRR ligands. After 48 hours of incubation
in a humid chamber, cells were washed three times with 1X phosphate buffered saline
(PBS). Fresh media was added along with PRR ligands at a specific concentration in
duplicates. A negative control well was setup for each experiment. Each experiment was
carried out in triplicates.
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5.2.2 PRR ligands for stimulation of BIEC-c4 cells
BIEC-c4 cells were stimulated with PRR ligands for 3 and 24 hours using endtime alignment method. Lipopolysaccharide (LPS: catalog number L6529-1mg) from
Escherichia coli O55:B55 was used at 5 µg/ml concentration. Similarly, peptidoglycan
(PGN: catalog number tlrl-pgnsa) from Staphylococcus aureus was used at 10 µg/ml and
Flagellin (FLA: catalog number tlrl-stfla) from Salmonella typhimurium was used at 100
ng/ml. Cells from passage 55 -62 were used for stimulating BIEC-c4 cells with bacterial
ligands. We also stimulated cells (passage 32-42) for 3 hours and 24 hours using ligands
of cytoplasmic and endosomal PRRs. γ-D-Glu-mDAP (iE-DAP: catalog number tlrl-dap)
was used at10 µg/ml, muramyl dipeptide (MDP: catalog number tlrl-mdp) at 10 µg/ml,
polyinosonic:polycytidylic acid (Poly I:C: catalog number tlrl-pic) at 5 µg/ml, Poly I:C
complexed with lyovec (Poly I:C/lyovec: catalog number tlrl-piclv) at1 µg/ml, and
Imiquimod (catalog number tlrl-imq) at 5 µg/ml. All PRRs ligands were bought from
Invivogen, CA, USA.
5.2.3 RNA extraction and cDNA preparation
After 3 hours or 24 hours of incubation with ligands, cells were washed three
times with 1X PBS. Cells were then trypsinized using 0.05% Trypsin-EDTA and
centrifuged to form a pellet. RNA was extracted from pelleted cells using RNeasy Mini
Kit (catalog number 74101, Qiagen, Valencia, CA, USA) and kit protocol. RNA was
quantified using Thermo Scientific™ NanoDrop 2000. The RNA thus obtained was used
to prepare cDNA. 1 µg of RNA was reverse transcribed to cDNA using TaqMan reverse
transcription kit and kit protocol (TaqMan reverse transcription reagents, Applied
Biosystems, catalog number N8080234).
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5.2.4 RT-qPCR for quantifying gene expression
For RT-qPCR 2 µl of diluted cDNA (1:5 dilution), 1 µl each of forward and
reverse primer, 10 µl of RT² SYBR® Green/ROX qPCR mastermix (catalog number
330501, Qiagen, Valencia, CA, USA) and 6 µl of nuclease free water was added. The
thermal profile used for amplification was: 2 minutes at 500C; 10 minutes at 950C;
followed by 40 cycles of 45 seconds (15 seconds for cytokine genes) at 950C, 30 seconds
at 600C and 30 seconds at 720C. Ramping speed was set at 1.60C/second. QuantStudio™
6 Flex Real-Time PCR System (Applied Biosystems, NJ, USA) was used. Data were
normalized using housekeeping gene hypoxanthine phosphoribosyl transferase 1 (Hprt1). Primer sequence previously used (138) for amplification of bovine TLR 1-9 gene,
cytokine genes (138, 200) and Hprt-1 as housekeeping gene (278) are listed in Table 7
and 8. RT-qPCR was used to identify any changes in TLRs, pro-inflammatory and antiinflammatory cytokines, after stimulation with PRR ligands.
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Table 7: Primer sequence of genes along with gene bank accession number used in
analysis of TLRs expression of BIEC-c4 cells
Forward primer

Reverse primer

Accession
number

TLR 1

TLR 2

TLR 3

TLR 4

TLR 5

TLR 6

TLR 7

TLR 8

TLR 9

Hprt-1

CAT TCC TAG CAG CTA

TGG GCC ATT CCA AAT

NM_001046

CCA CAA GCT

AAG TTC T

504

GGG TGC TGT GTC ACC

GCC ACG CCC ACA TCA

NM_174197

GTT TC

TCT

GGG CAC CTG GAG GTC TTC CTG GCC TGT GAG

NM_001008

CTT

TTC TTG

664

AGC ACC TAT GAT GCC

GTT CAT TCC GCA CCC

NM_174198

TTT GTC A

AGT CT

GTC CCC AAC ACC ACC

GCG GTT GTG ACT GTC

NM_001040

AAG AG

CTG ATA TAG

501

TTT ACC CTC AAC CAC

GGG CCA AAG GAA CTG

NM_001001

GTG GAA

AAA AAC

159

CAC CAA CCT TAC CCT

GTC CAG CCG GTG AAA

NM_001033

CAC CAT T

GGA

761

TGT GTT TAG AGG AAA

TCT GCA TGA GGT TGT

NM_001033

GGG ATT GG

CGA TGA

937

CAG TGG CCA GGG

CCG GTT ATA GAA GTG

NM_183081

TAG TTT CTG

ACG GTT GT

GGATTACATCAAAGCA

CATTGTCTTCCCAGTGTCA

NM_001034

CTGAACA

ATT

035
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Table 8: Primer sequence of genes along with gene bank accession number used in
analysis of cytokines expression of BIEC-c4 cells
Forward primer

Reverse primer

Accession
number

IL-1α

IL-1β

CAG TTG CCC ATC CAA

TGC CAT GTG CAC CAA

NM_174092

AGT TGT T

TTT TT

GAG CCT GTC ATC TTC

GCA CGG GTG CGT CAC A

NM_174093

CGC ATT GCA GTC TCC

GGG CTC TTG ATG GCA

NM_173966

TAC CA

GAC A

GAA ACG
TNF-α

IL-6

IL-8

IL-10

CCA CCC CAG GCA GAC CCA TGC GCT TAA TGA
TAC TTC

GAG CTT

TGC TCT CTT GGC AGC

TCT TGA CAG AAC TGC

TTT CC

AGC TTC AC

AAGGTGAAGAGAGTCT

TGCATCTTCGTTGTCATGT

TCAGTGAGC

AGG

NM_173923

NM_173925

NM_174088

5.2.5 Statistical analysis for interpretation of RT-qPCR data
To compare the change in TLR expression after ligand stimulation, double delta
Ct (ΔΔCt) was calculated using the method previously described (201). Change in
mRNA gene expression was calculated as 2-ΔΔCt. The method uses the following
equation to calculate ΔΔCt:
ΔΔCt=∆Ct Treatment (Ct of reference gene Treatment-Ct Housekeeping gene
Treatment)- ∆Ct Control (Ct of reference gene Control-Ct Housekeeping gene Control).
A two tailed Student’s t-test was then used to compare fold expression changes
after treatment with ligands. A p-value of less than 0.05 (p<0.05) was considered
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significant. GraphPad prism 7.04 was used to prepare graphs. Data are expressed as a
mean ± standard error of the mean.
5.3 Results
5.3.1 Responses of BIEC-c4 cells at 3-hour and 24-hour after stimulation with
bacterial ligands of surface expressed PRRs
Three hours stimulation of BIEC-c4 cell with bacterial ligands LPS, PGN and
FLA resulted in no significant changes in TLRs genes expressions (Figure 29-31). At 24hour, PGN significantly upregulated TLR 3 (1.73±0.14, p=0.04), and TLR 9 (1.41±0.07,
p=0.03) gene expression (Figure 30). LPS significantly upregulated cytokines IL-10
(2.42±0.2, p=0.02), and IL-8 (9.78±1.83, p=0.04) gene expression after 3-hour
stimulation. At 24 hour, LPS also significantly upregulated IL-6 (3.58±0.15, p=0.00), and
IL-8 (12.99±2.06, p=0.03) (Figure 32). PGN stimulation did not induce any significant
changes in any cytokine gene expression at both 3 hours and 24 hour time points. FLA at
3-hour downregulated IL-1β (0.31±0.1, p=0.02) (Figure 34) gene expression.
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Fig 29: Fold changes in TLRs genes expressions in BIEC-c4 cells upon stimulation with
LPS. Data are expressed as a mean of 3 independent experiments and error bar represents
standard error of the mean. A significant difference in gene expression after LPS
treatment is denoted by an asterisk (*=p<0.05, **=p≤0.01).
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Fig 30: Fold changes in TLRs genes expressions in BIEC-c4 cells upon stimulation with
PGN. Data are expressed as a mean of 3 independent experiments and error bar
represents standard error of the mean. A significant difference in gene expression after
PGN treatment is denoted by an asterisk (*=p<0.05, **=p≤0.01).
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Fig 31: Fold changes in TLRs genes expressions in BIEC-c4 cells upon stimulation with
FLA. Data are expressed as a mean of 3 independent experiments and error bar represents
standard error of the mean. A significant difference in gene expression after FLA
treatment is denoted by an asterisk (*=p<0.05, **=p≤0.01).
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Fig 32: Fold changes in cytokines genes expressions in BIEC-c4 cells upon stimulation
with LPS. Data are expressed as a mean of 3 independent experiments and error bar
represents standard error of the mean. A significant difference in gene expression after
LPS treatment is denoted by an asterisk (*=p<0.05, **=p≤0.01).
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Fig 33: Fold changes in cytokines genes expressions in BIEC-c4 cells upon stimulation
with PGN. Data are expressed as a mean of 3 independent experiments and error bar
represents standard error of the mean. A significant difference in gene expression after
PGN treatment is denoted by an asterisk (*=p<0.05, **=p≤0.01).
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Fig 34: Fold changes in cytokines genes expressions in BIEC-c4 cells upon stimulation
with FLA. Data are expressed as a mean of 3 independent experiments and error bar
represents standard error of the mean. A significant difference in gene expression after
FLA treatment is denoted by an asterisk (*=p<0.05, **=p≤0.01).
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5.3.2 The responses of BIEC-c4 cells at 3-hour and 24-hour after stimulation with
ligands of cytoplasmic and endosomal PRRs
Out of various ligands of cytoplasmic and endosomal PRRs, only iE-DAP, MDP,
and poly (I:C) altered the expression of TLRs in BIEC-c4 cells. iE-DAP stimulation at 3
hours significantly upregulated the expression of TLR 9 gene but expression of none of
the other TLRs was affected (Figure 35). MDP after 24-hour stimulation upregulated
TLR 9 (2.13±0.14, p=0.01) (Figure 36). Poly (I:C) after 3-hour stimulation upregulated
TLR 8 (3.9±0.54, p=0.03), and TLR 9 (7.41±1.0, p=0.02) (Figure 37) gene expression. In
general, we observed no alteration in TLRs expressions after 24 hours of stimulation with
any ligands of cytoplasmic and endosomal PRRs except MDP (Figure 35-39).
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Fig 35: Fold changes in TLRs genes expressions in BIEC-c4 cells upon stimulation with
iE-DAP. Data are expressed as a mean of 3 independent experiments and error bar
represents standard error of the mean. A significant difference in gene expression after
iE-DAP treatment is denoted by an asterisk (*=p<0.05, **=p≤0.01).
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Fig 36: Fold changes in TLRs genes expressions in BIEC-c4 cells upon stimulation with
MDP. Data are expressed as a mean of 3 independent experiments and error bar
represents standard error of the mean. A significant difference in gene expression after
MDP treatment is denoted by an asterisk (*=p<0.05, **=p≤0.01).
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Fig 37: Fold changes in TLRs genes expressions in BIEC-c4 cells upon stimulation with
Poly (I:C). Data are expressed as a mean of 3 independent experiments and error bar
represents standard error of the mean. A significant difference in gene expression after
Poly (I:C) treatment is denoted by an asterisk (*=p<0.05, **=p≤0.01).
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Fig 38: Fold changes in TLRs genes expressions in BIEC-c4 cells upon stimulation with
Poly (I:C)/Lyovec. Data are expressed as a mean of 3 independent experiments and error
bar represents standard error of the mean. A significant difference in gene expression
after Poly (I:C)/Lyovec treatment is denoted by an asterisk (*=p<0.05, **=p≤0.01)
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Fig 39: Fold changes in TLRs genes expressions in BIEC-c4 cells upon stimulation with
imiquimod. Data are expressed as a mean of 3 independent experiments and error bar
represents standard error of the mean. A significant difference in gene expression after
imiquimod treatment is denoted by an asterisk (*=p<0.05, **=p≤0.01).
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5.4 Discussion
Host-specific in-vitro system that expresses PRRs and responds to PAMPs is
essential for studying disease pathogenesis and host immune responses against
pathogens. In this study, BIEC-c4 cells expressed various TLRs and responded to various
bacterial associated ligands of PRRs by changing the expression of TLRs, proinflammatory and anti-inflammatory cytokines.
The intestinal epithelium is constantly exposed to the gut microbiota. There is a
dynamic interaction between intestinal mucosa and gut microbes. Investigating these
interactions is essential for better understanding of inflammatory and enteric diseases
where this delicate interaction is perturbed (279). Intestinal epithelium should
expediently detect pathogens from commensals and mount an effective immune response.
PRRs especially TLRs, NLRs, RLRs recognize molecular patterns conserved across the
pathogens. Pathogen sensing by PRRs results in activation of transcription factors and
ultimately release of cytokines, chemokines and growth factors (280). Cytokines and
chemokines released in intestinal lumen are key players in regulating barrier integrity
(195, 204). Understanding cell specific responses and intracellular mechanisms that
generate innate immune responses against enteric pathogens are crucial for the
development of control methods against such pathogens (126).
In this study, we first analyzed putative TLRs 1-9 expression in BIEC-c4 cells. To
identify if these cells respond to various pathogen associated molecular patterns (PAMPs)
and initiate any downstream signaling, we stimulated cells for either 3 hours or 24 hours
with various ligands of PRRs. Stimulation for 3 hours mimicked early innate immune
responses while 24 hours point mimicked late innate immune responses. LPS did not alter
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expression of various TLRs genes at 3-hour or 24-hour stimulation. However, we
observed upregulation of IL-8 and IL-10 genes at 3 hours and IL-6 and IL-8 at 24-hour
after LPS stimulation. LPS from gram negative bacteria is a potent immunostimulatory
structure. LPS consists of endotoxin Lipid A, core oligosaccharide, and O-antigen. Lipid
A is recognized by TLR 4 (205, 206). LPS recognition by TLR 4 requires accessory
molecules. LPS binding protein binds to LPS allowing the association between LPS and
co-receptor CD14 (monocyte differentiating antigen). CD14 facilitates the binding of
LPS to TLR 4/MD-2 complex (207, 208). Recognition of LPS by TLR 4 leads to signal
transduction either by MyD88 (209) or by TRIF pathway (210) ultimately leading to
activation of transcription factors like NF-κB, AP-1, and IRF-3. Activation of
transcription factors results in expression of pro-inflammatory cytokines like IL-6, IL-8,
TNF-α, and Type -I IFN (20, 211). Previous studies have shown that stimulation of
bovine intestinal epithelial cells by E. coli PAMPs resulted in increased expression of
pro-inflammatory cytokines like IL-6, IL-8, IL-1α, IL-1β (138, 265). Continued
activation of TLR 4 can lead to inflammation induced damages and thus negative
regulation needs to be in place. Radioprotective protein 105 (RP105), single
immunoglobulin IL-1R-related molecule, and IL1-RL1 protein negatively regulate TLR 4
signaling. LPS challenged mice that are deficient for RP105 showed elevated levels of
TNF-α in serum (213). After TLR signaling, the LPS-TLR4-MD2 complex is
endocytosed in endosome or lysosomes where degradation of TLR 4 occurs (214). This
degradation can result in the termination of TLR 4 induced production of TNF (215).
Peptidoglycan (PGN) is a major constituent of gram positive bacteria and is
composed of N-acetlyglucosamine (GlcNac) and N-acetylmuramic acid (MurNac) linked
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by β-(1-4) linkage (49). PGN’s role in producing an inflammatory response and
stimulating immune response has been long known (50, 51). TLR 2 knocked out mice
revealed that TLR 2 is involved in recognition of PGN (216). In various cell models,
PGN induces production of pro-inflammatory cytokines like IL-6, IL-1α/β, TNF-α (217).
In this study, TLR 3 and TLR 9 genes expressions were significantly upregulated at 24
hours after PGN stimulation although no changes in cytokine expression were observed.
PGN stimulation did not alter TLR 2 expression at 3-hour or 24-hour time points and
showed no significant changes in cytokine expression. In other in-vitro models, cells
responded to PGN treatment by altering the expression of TLRs other than TLR 2 (219).
TLR 1 and TLR 6 are functionally co-related with TLR 2 in recognizing different classes
of lipopeptides (220). Most of the studies co-relating PGN to TLR 2 used commercially
obtained PGN from Staphylococcus aureus. This preparation is often co-purified with
other cell wall components and pure PGN has failed to respond to TLR 2 in many
experiments (221). The authors (221) even claimed that PGN sensing did not occur via
TLR 2 which was later refuted (222).
Flagellin (FLA), a subunit of flagellum protein, provides motility to the
bacterium. Initially considered as a virulence factor, subsequent in-vitro studies
demonstrated its pro-inflammatory role (223, 224). Later it was demonstrated that
recognition of flagellin by TLR 5 induced production of pro-inflammatory cytokines like
TNF-α, IL-1β (225). In this study, 3-hour and 24-hourstimulation of BIEC-c4 cells with
flagellin did not alter expression of any TLRs but downregulated IL-1β at 3-hour time
point. Recent studies have shown cross talk among various PRRs and that specific PRR
ligand can overexpress or inhibit expression of other PRRs. Among multiple ligands, LPS
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showed a more pronounced effect on modulating expression of other PRRs, and PAMPs
other than LPS downregulated the expression of TLR 4 (226). Triggering of single TLR
when the specific ligand is recognized is insufficient to mount an effective innate
immune response and thus triggering of other PRR family or multiple TLRs may be
required to mount a strong immune response. Often the synergism exists between PRRs
that mediate effector response through different signaling pathways (43, 227).
Nucleotide-binding oligomerization domain (NOD) proteins are cytoplasmic
proteins involved in recognition of intracellular bacteria. NOD proteins have N-terminal
caspase recruitment domain (CARD), leucine rich repeats in C-terminus and nucleotide
binding domain in between. NOD-1 and NOD-2 are two NOD proteins that recognize
two different peptidoglycan fragments and are involved in pathogen recognition (48).
NOD-1/CARD4 recognizes peptidoglycan GlcNac-MurNac-L-Ala-γ-D-Glu-meso-DAP
(GM-TriDAP/iE-DAP) whereas NOD-2 recognizes muramyl dipeptide, MurNac-LAlaD-isoGln. NOD-1 and NOD-2 activate NF-κB by recruitment of receptor-interacting
protein (RIP) 2 leading to secretion of pro-inflammatory cytokines while type I
interferons are secreted when IRF3/IRF7 dependent pathway is activated by these
receptors (52-56). In this study, iE-DAP upregulated expression of TLR 9 gene
expression at 24 hours after stimulation in BIEC-c4 cells while MDP upregulated TLR 9
gene after 3-hour stimulation. MDP alone has been shown to evoke weak immune
stimulation (47, 228-231). Addition of TLR agonists like LPS, lipoteichoic acid along
with MDP has been shown to evoke a strong immune response (232, 233). TLR
stimulation may promote internalization of MDP and iE-DAP which facilitates
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recognition by NOD proteins. NOD proteins also interact with other intracellular
molecules that positively or negatively regulate NOD signaling pathways (47).
During viral replication, most of the viruses produce double stranded RNA
(dsRNA) as replication intermediate. This dsRNA is sensed by PRRs present in the
cytosol, and endosomes. TLR 3 is membrane receptor usually present in endosomes and
recognizes dsRNA. Retinoic acid-inducible gene I (RIG-I), melanoma differentiationassociated gene -5 (MDA-5), and NLR pyrin domain 3 (Nlrp3) are present in the cytosol
and associated with sensing of dsRNA (62, 234-237). Recognition of dsRNA by these
receptors results in the production of type -I interferon (IFN) (238, 239). TLR 3 uses
MyD88 independent pathway and uses toll/interleukin-1 receptor (TIR) domaincontaining adaptor inducing IFN-β (TRIF) ultimately leading to induction of IFN-β (210,
240, 241). Poly (I:C) is the synthetic analog of dsRNA and is used to mimic viral
infection in experimental conditions (242, 243). Recent reports have shown possible role
of CD14 in internalizing extracellular dsRNA or poly (I:C) and delivering it to TLR 3
located in the endosomal and lysosomal membrane (244). Apart from IFN, IL-6 induced
from TLR 3 expression is reported to have a detrimental effect during infection with
single stranded RNA viruses (245-247). Apart from IFN production, NF-κB activation
also induces secretion of IL-32. IL-32 induces production of pro-inflammatory cytokines
like IL-6, IL-8, TNF-α, IL-1β (241, 248). In BIEC-c4 cells, we observed upregulation of
TLR 8 and TLR 9 at 3-hour stimulation with poly (I:C). However, we did not observe
any significant changes in TLR 3 expression.
Poly (I:C) complexed with transfecting reagent lyovec did not induce any
significant changes in TLRs expressions in BIEC-c4 cells. Accumulation of intracellular
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dsRNA during viral replication and subsequent induction of IFN production by the host
cell is different from the IFN produced by sensing of extracellular dsRNA (249).
Intracellular dsRNA is sensed by RIG-I, MDA-5. RIG-I and MDA-5 belong to RIG-I like
receptor (RLR) family. RIG-I senses blunt ended 5’phosphorylated dsRNA whereas
MDA-5 recognizes long (>1000 nucleotide) dsRNA (58-60) Both RIG-I and MDA-5 are
RNA helicases that have caspase recruitment domain (CARD) and helicase domain.
Signal transduction after sensing of intracellular dsRNA is through CARD in both RIG-I
and MDA-5. This results in activation of IRF-3 and NF-κB and subsequent production of
IFNs (type I, and type III) and as well as pro-inflammatory cytokines like IL-6 and IL-8
(61-64).
Imiquimod is a synthetic guanosine analog with antiviral and anti-tumor activity
(250). Imiquimod is an immune response modifier that specifically activates TLR 7
signaling pathway (251). Through MyD88 signaling cascade imiquimod induces
activation of transcription factors like NF-κB, and MAPKs (mitogen activated protein
kinases). Activation of these transcription factors lead to the induction of IFN-α, IL-12,
TNF-α, IL-6 and other cytokines (250, 252-255). In this study, BIEC-c4 cells did not
respond to imiquimod stimulation although they have been shown to express TLR 7 gene.
Immune cells like phagocytes produce reactive oxygen species (ROS) during the
microbial invasion. These ROS are highly reactive and induce oxidative damage to
nucleic acids, lipids, and proteins. The Guanosine and cytosine are more prone to
undergo oxidative damage due to their electronic configuration. The damaged guanosine
may be sensed by TLR 7 and TLR 8 and produce necessary cytokines for activating
immune cells (251, 256).
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In this study, we studied the putative expression of TLRs by BIEC-c4 cells. There
are limited number of studies on the expression of PRRs by the bovine ileal epithelial cell
line. To the author's knowledge, no studies on the role of the bovine ileal epithelial cell
line in innate immunity have been carried out. This study also analyzed the response of
bovine ISEMFs to various PAMPs and associated cytokine expression but did not
analyze expression of NLRs and RLRs genes. This study only analyzed changes in gene
expression in response to various PAMPs. This study is limited in that it did not analyze
whether alteration in mRNA expression was being carried out to protein level. No
experiment to quantify cytokine levels in cell culture supernatant was performed and
changes in IFN gene in response to viral PAMPs was not analyzed. Despite these
limitations, we demonstrated that bovine BIECs express TLRs 1-9 and respond to various
bacterial PAMPs. These cells failed to respond to ligands of many cytoplasmic and
endosomal PRRs. These cloned epithelial cells were homogenous in distribution and thus
are not a true representative of tissue environment. These BIEC-c4 cells did not polarize,
were spontaneously immortalized and did not allow replication of bovine rotavirus,
bovine coronavirus and bovine viral diarrhea virus (unpublished data). We concluded that
these are immature or undifferentiated epithelial cells. The BIEC-c4 clone could have
arisen from intestinal stem cells and thus did not respond properly to ligands of
cytoplasmic and endosomal PRRs. These cells were established from the 2-day old calf.
Recent studies have shown that insufficient colonization by gut microbiota can lead to the
defective immune system. Sufficient colonization by gut microbiota is essential for a
fully functional immune system (281).
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5.5 Conclusion
Based on this study we conclude that BIEC-c4 cells express TLRs 1-9 and
respond to many bacterial PAMPs. Thus, these cell line can be used to accumulate
knowledge of signal transduction in response to various bacterial PAMPs such as LPS,
PGN and FLA. However, BIEC-c4 cell line did not respond to viral PAMPs.
Differentiating these cells into more mature epithelial cells and analyzing their responses
to ligands of cytoplasmic and endosomal PRRs can help decide their relevance as an invitro model. However, these cell line can be a good in-vitro model to study enteric
bacterial pathogens.
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Chapter 6: Conclusions and future directions
We successfully developed primary ileal myofibroblast cultures from the 2-day
old bovine calf. These ileal intestinal sub-epithelial myofibroblasts (ISEMFs) showed
phenotypic characteristics typical of myofibroblasts. On immunocytochemistry ISEMFs
demonstrated the presence of α-smooth muscle actin and vimentin. But absence of
cytokeratin which confirmed the presence of pure myofibroblast cells. Since primary
cells can be grown for finite passages, we immortalized primary ileal ISEMFs using
SV40 large T antigen. Glycobiology of primary ISEMF cells and immortalized ISEMFs
showed differences for some lectins. TLR expression analysis showed no differences
between primary and immortalized ISEMFs.
Earlier we had established primary bovine ileal epithelial cells (BIEC-c4) in our
lab. Both primary ISEMFs and primary BIEC-c4 cells were from same calf and same
ileal segment. In this study, we analyzed if both BIEC-c4 and ISEMF cells respond to
various PAMPs. On analysis, both BIEC-c4 and ISEMF responded to bacterial PAMPs
while only ISEMF mainly responded to ligands of cytoplasmic and endosomal PRRs.
Based on our finding we concluded that bovine ISEMFs can be a good model to
study innate immune responses occurring at sub-epithelial compartment. Primary ISEMF
cells can also be used to study PRRs signaling pathways. ISEMF cells have emerged as a
mediator of diverse functions. ISEMFs are involved in wound healing, regulation of
barrier function of the intestinal epithelium, differentiation and maturation of epithelium
and in generating innate immune responses occurring at sub-epithelial compartment.
ISEMF cells developed and characterized in our lab can be a good model to study
intestinal inflammatory disease pathogenesis as well.
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BIEC-c4 cells responded only to bacterial PAMPs. BIEC-c4 cells established in
our lab was a cloned cell line. BIEC-c4 cells behaved like stem cells as they did not
polarize on culture and kept growing for more than 100 passages without
immortalization. Since they responded to bacterial PAMPs, we concluded that these cells
can be used to study enteric bacterial disease pathogenesis.
Since our findings were based on RT-qPCR assay, further studies to corroborate
these findings at protein levels are essential. Western blot to detect changes in TLR
proteins upon stimulation with PAMPs can bolster the findings. Cytokine ELISA of cell
supernatants after stimulation with PAMPs can further support our data. Bacterial
invasion assay on this BIEC-c4 cells and subsequent analysis of TLRs expression could
mimic in-vivo conditions. Transforming immature BIEC-c4 cells to more mature and
differentiated epithelial cells expressing tight junction proteins should be carried out. A
2D co-culture of primary ISEMF and BIEC-c4 cells to investigate ISEMFs role in
maturation and differentiation of intestinal epithelial could be next project using these
cells.
Overstimulation of TLRs often leads to excessive cytokine production which can
be detrimental to host. A detailed understanding of key signaling molecules involved in
TLR signaling in these cells as a model can be beneficial in developing therapeutic
strategies of various infectious diseases.
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